First steps in optimizing breast screening in Mongolia: Understanding radiologists’ performance in reading mammograms and mammographic breast density by Demchig, Delgermaa
46 
 
 
 
 
 
First steps in optimizing breast screening in Mongolia: 
Understanding radiologists’ performance in reading 
mammograms and mammographic breast density 
 
 
 
 
 
Delgermaa Demchig 
 
 
A thesis is submitted in fulfilment of the requirement for the degree of  
Doctor of Philosophy 
 
 
 
 
 
 
 
Faculty of Health Science 
The University of Sydney 
2018 
i 
 
Candidate’s statement 
 
 
 
I, Delgermaa Demchig, hereby certify that this thesis is the result of my full time 
study and my original work, which has not been published or accepted for an award 
of any other degree previously. I further declare that all sources cited or quoted are 
indicated and acknowledged by means of a comprehensive list of references.   
 
I, Delgermaa Demchig, am aware that if a higher degree is awarded for my thesis 
entitled “First steps in optimising breast screening in Mongolia: Understanding 
radiologists’ performance in reading mammograms and mammographic breast 
density” which is submitted for examination, this thesis will be lodged in the 
University Library and be available immediately for use. I understand that the 
librarian of the Head of Faculty may provide a copied version of this thesis to an 
individual for study or research purposes or to library.   
 
 
 
Signed:  
Date: 01 June 2018 
 
 
 
 
 
 
ii 
 
Table of Contents 
 
Candidate statement..................................................................................................i 
Acknowledgment...................................................................................................... v 
Publications and Presentations ……………………………………...……...….……viii 
Publications..….………………………..…………………………………………..viii 
Presentations.………….…………..……………………………..…………………ix 
Preface........................................................................................................................x 
Abstract..…...............................................................................................................xii 
List of table..…………………………………………………………………...………....xiv 
List of figure……………………………………………………………………..………...xv 
 
CHAPTER ONE.………………………………………………………………………..…...1 
Introduction…...……………..………………………………………………….….………...1 
1.1 Background.……………………………………………………..………..……….…….2 
1.1.1  Breast cancer in the world..……………..………………..…….…..……..2  
1.1.2  Breast cancer in Mongolia..……………………………….…….…...........3 
1.1.3 Breast cancer challenges in Mongolia………………….………….……...4 
1.2  Breast cancer diagnosis…………………………………………..………….....……. 5  
1.2.1 Breast cancer screening in developed countries………………...……. 6 
1.2.2 Breast cancer screening in developing countries...…….………….......9 
1.3  Difficulties in breast cancer detection …………..………………………….……….. 9 
1.3.1 Interpretive performance of radiologists.…………..…………….…….10 
1.3.2 Mammographic breast density.……………………..…………………..13 
1.4  Deficiencies in the literature………………………………………………….……... 15 
iii 
 
1.5  Aims and objectives……………………………………………………...….…...….. 18 
1.6  Thesis structure.…..………………………………………………………….…….....19 
1.7  References………………………………………………………………….………... 22 
CHAPTER TWO………………………………………….………………………………. 30 
“Breast cancer in Mongolia: An increasingly important health policy 
issue”…......................................................................................................................30 
2.1 Statement of authorship.……………………………………………………...31 
2.2 Bridging section for chapter two.……………………………….……….…...32 
2.3 References…………………………………………………………….…….....35 
CHAPTER THREE………………………………………….………………………….….44 
“Mammographic detection of breast cancer in a non-screening country”…..……….46 
3.1 Statement of authorship……………………………………………………....47  
3.2 Bridging section for chapter three…………………………………….……..48 
3.3 References…………………………………………………………..…………51 
CHAPTER FOUR………………………………………………………………………… 59 
“Observer variability in breast cancer diagnosis between countries with and without 
mammographic screening”……..………………………………………………..……….59 
4.1 Statement of authorship………………………………………………………60 
4.2 Bridging section for chapter four……………………………………………..61 
4.3 References……………………………………………………………………..64 
CHAPTER FIVE.………………………………………………………………………..….73  
“Mammographic appearances in Mongolia: causal factors for varying 
densities”….…………………………………………………………………………….…..73 
5.1 Statement of authorship.………………………………………………….…..74 
5.2 Bridging section for chapter five.….………………………………………....75 
iv 
 
5.3 References…………………………………….……………………………….78 
CHAPTER SIX……………………………………………………………………………. 86 
Discussion...………………………………………………………………………………. 86 
6.1  An overview of the thesis……………………………….………………………..87 
6.2  Significant findings ………………………………………………………………..91 
6.3  Implications ………………………………………………………………………..94 
6.4  Limitations……………………………………………………………………….....97 
6.5  Future directions…………………………………………………………………100 
6.6  The output of the thesis……………………………………………….………...101 
6.7  Conclusion..…………………………………………………….………………...103 
6.8  References……………………………………………………………………….105 
 
Appendix 1………………………………………………………………………….........108 
Materials used in the study.……………………………………………………………..108 
Appendix 1.1 Ethical approval – The University of Sydney.…………………..….109 
Appendix 1.2 Ethical approval – The Ministry of Health, Mongolia………..…….115 
Appendix 1.3 Data collection approval – National Cancer Centre of Mongolia...118 
Appendix 1.4 Data collection approval – BREAST………………………………...121 
Appendix 1.5 Participant information sheet………………………………….……..130 
Appendix 1.6 Participant consent form……………………………………………...134  
Appendix 1.7 Safety protocol………………………………………………………...137 
 
 
 
 
 
v 
 
Acknowledgment 
 
 
First and foremost, I would like to thank my amazing supervisor Professor Patrick 
Brennan, for the outstanding supervision and guidance provided me during my 
study. After the first Skype meeting in early 2014, I felt that to be mentored by you 
would be a privilege. I consider myself extremely fortunate to have had a supervisor 
who has cared my project so deeply and always support my ideas without any 
discouragement. You have been an outstanding teacher and my role model in 
academia and particularly I am so grateful for your patience and commitment to my 
manuscript drafts with your excellent comments and suggestions.  
 
I would like to extend my sincere appreciation to number of other people who have 
provided me support. First, my co-supervisor, Associate Professor Claudia Mello-
Thoms, whose insightful comments and feedbacks to my manuscript drafts were 
invaluable for the publication. I thank her for the hard questions, which lead me to 
widen my research from various perspectives. Second, I am grateful to Professor 
Mary Rickard for being a role model and great teacher in professional life (radiology). 
You provided me an opportunity to practise mammography in Australia and this will 
undoubtedly help my future career. You have been a great source of inspiration and 
will be my lifetime mentor and friend. Third, my best friend in Australia, Ms Ziba 
Gandomkar, whose excellent knowledge of statistics was important to clarify my 
uncertainties on data analysis. I really appreciate your willingness to help my work 
and for being next to me supporting in different ways.  
 
vi 
 
To the rest of my team, Professor Asai Ramish, Dr Khulan Khurelsukh, Dr Undrakh-
Erdene Erdenebulgan, Dr Nyamdulam Sodnomdargia and Dr Rob Herald, thank you 
for the outstanding support and encouragement during my journey. Without the help 
of Amy, Bojan, Annie and Susan from Australia Award Office at the USYD, the work 
also would not have been possible. I would also like to thank all participating 
radiologists from Mongolia for their time and enthusiasm. 
 
My biggest gratitude goes to the Australian Government for providing me a 
scholarship, without which I would not be able to afford the international student fees 
for my PhD. This work also could not have finished without the two collaborators we 
have in Mongolia, the National Cancer Centre and the INTERMED hospital.  
 
Last but not the least, I wish to thank my family, my mom and parents-in-laws for 
their support and encouragement during this journey. Very especial thanks to my 
husband for encouraging me and providing me strong and consistent support. Thank 
you for being there for me. Although stressful, undertaking a doctoral degree has 
been enjoyable with the laugh and jokes from my son. Thanks for the joy you bring to 
my heart. They are the most important people in my world and the completion of this 
work was possible with their generous support and encouragement.  
 
 
 
 
 
 
vii 
 
Dedication 
 
This thesis is dedicated to the memory of my father Mr Demchig Duger (02.04.1946 
– 18.06.1996). He was inspiration to pursue my doctoral degree and my life coach 
with his excellent knowledge and great attitude. His advice and comments would 
have added great source of perfections to my work.  
 
He died due to delayed arrival of emergency service in Mongolia and this was the 
reason I choose medical profession. At present time, delay in diagnosis and health 
care service has still been occurred in Mongolia especially for cancer cases. I hope 
this thesis can help further in small ways to improve the diagnosis and better 
outcomes for all sufferers of breast cancer in Mongolia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
Publications and Presentations 
 
 
Parts of the work presented in this thesis have been published and presented in the 
following forums:   
 
Publications 
 
[1] Demchig, D., C. Mello-Thoms, and P.C. Brennan, “Breast cancer in 
Mongolia: an increasingly important health policy issue.” Breast Cancer 
Targets and Therapy, 2017. 9: p. 29-38. 
 
[2] Demchig D, Mello-Thoms C, Khurelsukh Kh, Ramish A, and Brennan C 
“Mammographic Appearances in Mongolia: Casual Factors for Varying 
Densities.” Asian Pacific Journal of Cancer Prevention, 2017 18(9): p. 2425-
2430 
 
[3] Demchig D, Mello-Thoms C, Lee W, Khurelsukh Kh, Ramish A, and P.C 
Brennan, “Observer Variability in Breast Cancer Diagnosis between Countries 
with and without Breast Screening.” Academic Radiology, 2018, in press. 
 
[4] Demchig D, Mello-Thoms C, Lee WB, Khurelsukh Kh, Ramish A, and 
Brennan P.C, “Mammographic detection of breast cancer in a non-screening 
country.” Br J RAdiol 2018; 91: 20180071.  
 
 
ix 
 
Conference presentations 
 
[1] Demchig D, Mello-Thoms C, Brennan C. “Mammographic appearances 
amongst Mongolian women: A first step towards optimising screening 
practices,” Sydney Cancer Conference, September 2016, Sydney Australia. 
 
[2] Demchig D, Mello-Thoms C, Khurelsukh Kh, Ramish A, and Brennan C, 
“Mammographic density in Mongolia. 6th Asia Pacific Breast Cancer Summit,” 
February 2017, Hong Kong. 
 
[3] Demchig D, Mello-Thoms C, Khurelsukh Kh, Ramish A, and Brennan C, 
“Detection of early breast cancer: Varying performances in mammographic 
interpretation of radiologists from screening and non-screening countries. 
103rd Scientific Assembly and Annual Meeting RSNA 2017,” November 2017, 
Chicago, USA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
Preface 
 
 
This thesis contains six chapters and each chapter was written to be read 
independently. The University of Sydney allows published papers that arose from the 
candidature to be included in the thesis.  
 
Ø Chapter one is an introduction to the thesis and provides an overview of the 
aim and objectives addressed by this thesis.  
 
Ø Chapter two is the literature review, which identified the key features of 
breast cancer in Mongolia. This paper is presented as published in the Breast 
Cancer Target and Therapy.    
 
Ø Chapter three is the first study in observer performance, investigating the 
level of diagnostic accuracy of Mongolian radiologists, using difficult 
mammographic images. This chapter is presented as published in the British 
Journal of Radiology.  
 
Ø Chapter four is the second study in observer performance exploring the 
mammographic performance of Mongolian radiologists using typical screening 
images. This chapter is presented as published in Academic Radiology.  
 
Ø Chapter five investigated the distribution of mammographic breast density for 
women in Mongolia. This chapter is presented as published in Asian Pacific 
Journal of Cancer Prevention.  
xi 
 
 
Ø Chapter six is the discussion, which describes the overview of the thesis, 
implications, limitations and future works and conclusions.  
 
Each chapter includes its own reference list. Ethical and relevant institutional 
approvals were obtained for this work prior to the data collection from Mongolia. To 
ensure that the readers understand the thesis as a whole, a bridging section is 
inserted in the beginning of each chapter apart from chapter one. The appendices at 
the end of this thesis include the materials used in this study. For the observer 
studies, informed consent was obtained from each participating radiologist from 
Mongolia. The need for informed consent with respect to use of patient materials 
was waived. In Mongolia, patients do not fill consent form when they undergo 
medical procedures and it is understood that patient related information can be used 
for research purposes. 
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Abstract 
 
 
Advanced diagnoses of breast cancer have become a serious public health issue in 
Mongolia. Whilst mammography has been proven to be an effective screening 
approach for breast cancer and well established amongst developed countries, such 
program has not been introduced in Mongolia. In addition in Mongolia, a lack of 
research around breast cancer continues to exist. The purpose of this thesis is to 
understand mammographic diagnostic accuracy and mammographic breast density 
(MD) in Mongolia, both of which are important considerations, which will inform a 
future national screening program. To address this aim, three studies were 
conducted; the first two were radiologists’ performance studies in reading 
mammograms with different levels of difficulty. The mammographic detection of 
Mongolian radiologists (case sensitivity of 63% and lesion sensitivity of 34%) was 
substantially lower compared with that of Australian radiologists. The third study 
investigated the MD features of 1985 Mongolian women using the Breast Imaging 
Reporting and Data system (BI-RADS) density categories. The majority of women 
(58%) were found to have low-density categories (category A and B) and significant 
associations were observed between MD; age (OR = 6.8, 95% CI: 5.5, 8.0), weight 
(OR = 4.5, 95% CI: 3.4, 6.0) and BMI (OR=13.2, 95% CI: 8.6, 20.0). Findings from 
this research have demonstrated that mammographic diagnostic accuracy is sub-
optimal in Mongolia. Moreover, images with different levels of difficulty did not alter 
the reading performance of Mongolian radiologists suggesting the need for improving 
breast cancer detection skills urgently. The output of this work also demonstrated 
that low density was predominant in Mongolia. The results will impact on health 
policy around screening in Mongolia. They will inform educational strategies that are 
xiii 
 
needed to transform diagnostic efficacy and will provide a good basis for decision 
making around screening modality choices.  
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Chapter 1 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
1.1  Background 
 
1.1.1 Breast cancer in the world 
 
Currently in the world, breast carcinoma is the most common cancer, constituting 
25% of all female cancers with an estimated 1.7 million new cases in 2012 [1]. 
Based upon economic capacity, countries seem to have differences regarding the 
incidence and characteristics of the disease. Overall, higher incidence rates continue 
to exist among developed countries such as North America and Australia/New 
Zealand while low incidence is observed in most of developing countries such as 
most of Africa and Asia [1, 2]. Disparities can be illustrated with age and stage at 
onset and pathological subtypes of breast cancer. The median age of breast cancer 
diagnosis for Asian women is reported to be 10 years younger than their Western 
counterparts, with a high proportion of diagnosis occurring under the age of 40. [3-5]. 
Furthermore, variations exist on the stage of breast cancer diagnosis between 
countries. For example, more than 50% of breast cancers in developed countries are 
detected at stage I, whilst this figure is closer to 20% among developing nations [3]. 
These variations in breast cancer between countries are mostly attributed to 
variations in risk factors, availability of early detection programs and access to 
treatment options.  
 
In addition, the disease appears to have favourable features among developed 
countries such as reduced mortality, stabilized incidence and high survival rates as a 
result of mammographic screening [6, 7] along with advancement in cancer 
treatment [8]. In contrast, the disease burden remains large among developing 
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countries due to high mortality, despite these nations having low incidence rates. It is 
well known that breast cancer is a disease of women in wealthy countries because a 
small occurrence of the disease has often been reported in developing countries due 
to the lack of screening. However, recent increases in incidence along with high 
mortality rates within a number of these developing nations require careful 
consideration from policy makers. Although the reasons are not fully understood, 
available explanations indicate that a transition to the westernised food, lifestyle and 
reproductive behaviour from a more traditional style plays an important role [1]. 
Understanding of these international variations is essential for cancer control 
strategies. 
 
1.1.2 Breast cancer in Mongolia 
 
Mongolia is a developing country in the north-central Asia with a population of just 
over three million people in 2017 [9]. In terms of ethnicity, the country has a quite 
homogenous population with about 90% and 10% of people belonging to Halh and 
non-Halh origins respectively [10]. Unlike most other countries, breast cancer is 
uncommon for women in Mongolia. In 2012, GLOBOCAN reported breast cancer to 
be the fifth most common cancer among Mongolian women with the age 
standardised rate (ASR) of 9.4/100,000 after liver, cervix uteri, stomach and 
oesophageal cancers [2]. However, similar to other Asian countries [3, 11] incidence 
rates are increasing on an annual basis. It also estimated breast cancer to be the 
sixth leading cause of cancer related death (3.7/100,000) for women in Mongolia. 
Within the country, geographical variations in incidence and mortality occur with the 
higher rates in urban areas where approximately 70% of population lives, [9] whilst 
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lower rates were recorded in rural areas with some regions having no data [12]. But, 
it should be acknowledged that quality of cancer registry in rural area remains 
unclear and therefore data quality is probably not high.   
 
The characteristics of breast cancer among Mongolian women also appear to be 
distinct. Similar to other Asian women, [11, 13] the disease presents at a younger 
median age (45-55 years old) than westernised women [14]. The low incidence of 
breast cancer in Mongolia has been linked to a high consumption of meat and dairy 
products, high rates of breastfeeding, low consumption of alcohol and a few people 
using cigarettes [15, 16]. Traditionally, Mongolian women tend to have higher 
number of kids than women in elsewhere, which may also contribute to the low risk 
for breast cancer: fertility rates (births per women) were reported to be 7.0 in 1975, 
but since then this figure has gradually declined and reached the current rate of 2.9 
in 2015 [17]. 
 
1.1.3 Breast cancer challenges in Mongolia 
 
Mongolia has seen a consistent increase in breast cancer incidence particularly in 
the last decade. For example, the reported number of cases for breast cancer has 
increased from 84 in 2009 to 173 in 2013. In terms of age standardised incidence 
rate (ASR), this figure have accounted for 3.0/100,000 in 2009 however in 2013, it 
was reported 6.0/100,000 [18]. Delivering health service in a timely manner remains 
difficult in Mongolia due to the sparse distribution of the population with an average 
1.9 people per square km [19]. This could be linked to the advanced presentation of 
breast cancer in the country. In Mongolia, delayed breast cancer diagnoses is 
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common with more than 90% of patients at an advanced stage [20, 21]. Although 
breast cancer incidence remains low, it has been increasing, highlighting the need to 
optimise diagnostic strategy. Whilst medical research is an essential part of any 
successful medical practice, in Mongolia there are very limited scientific publications 
around breast cancer. Although some data are available as described above, overall 
we are still unclear about type of women being affected, characteristics of breast 
cancer and underlying causes for advanced stage cancers in the country.   
 
When compared with other conditions, little focus has been directed towards breast 
cancer in Mongolia due to its traditional low prevalence resulting in slow progress 
towards effective preventative management. For example, primary diagnosis for liver 
cancer is widely available at all types of hospitals nationwide due to good availability 
of ultrasound technology and trained staff. In contrast, breast cancer diagnosis is 
only available in the capital city, Ulaanbaatar, where mammography and breast 
ultrasound are available at three medical centres including the national cancer centre 
(NCC). Nonetheless, a gradual but consistent increase in incidence along with more 
frequent diagnoses of later stage cancers in Mongolia have encouraged a greater 
awareness of the need for improved diagnosis, and treatment for breast cancer. 
Since primary prevention for breast cancer is not possible, an effective breast 
screening strategy will be the optimum approach for breast cancer management in 
Mongolia.  
 
1.2  Breast cancer diagnosis 
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Breast cancer is mostly detected with either screening or diagnostic examinations for 
women without and with symptoms. In both scenarios, mammography plays a key 
role in decision-making and is currently the front line tool for evaluating breast 
parenchyma. Whilst screening mammography ultimately aims to save lives 
throughout early detection of cancers, diagnostic mammography is designed to solve 
clinically presented findings, which are managed by radiologists. These two 
approaches also have very different characteristics and pathways such as cancer 
prevalence, later stage diagnoses are higher among diagnostic populations than the 
screening group, and therefore different procedures are required for interpretation. 
To date, strategies to diagnose breast cancer differs between countries, with 
developed countries relying heavily on screening program, whilst diagnostic 
examination remains dominant among developing nations. Perhaps this could be 
one of the main reasons why later stage cancers are not uncommon among 
developing countries; however, more scientific evidence is needed to understand 
potential causal factors of advanced disease presentation among developing 
countries.  
 
1.2.1 Breast cancer screening in developed countries 
 
Mammography is the frequently recommended screening approach worldwide and 
well established in developed countries. It is now strongly evident that 
mammographic screening (MS) has the advantage of an approximate 30% decrease 
in breast cancer death [6, 7, 22]. The supporting evidence of MS by a recent study 
revealed that the majority of breast cancer deaths (70%) occurred amongst 
unscreened women [23]. However, there has been much debate around the benefits 
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and risks of MS. For example, women with dense breasts have been central to the 
debate due to reported impact of density on sensitivity. Nonetheless, age to start 
screening varies between countries, being 50 years old in Australia [14] and Europe 
[24], whereas it ranges between 40 to 50 in the USA due to different 
recommendations by different institutions [24, 25]. With the debate around density, 
MS drawbacks further include overdiagnosis, false-positive (FP) results and 
variations in interpretation among radiologists. DCIS (ductal carcinoma in situ) 
diagnosed during screening round may be considered as an overdiagnosis, because 
of its probability of never becoming an invasive cancer [26] however differences 
between harmful and harmless DCISs remain unknown [27]. 
 
Mammography, whilst being the current front-line tool for breast cancer screening 
presents superimposed appearances of breast tissue, which limits diagnostic 
accuracy especially in dense background. To overcome overlying breast tissue, 
digital breast tomsynthesis (DBT) has recently been introduced in conjunction with 
conventional mammography. DBT provides more detailed structure of breast tissue 
especially better visualization of lesion margins and shapes than conventional 
mammography, which allows more confidence to reporting radiologists. When DBT 
is used for screening along with mammography, up to 50% increase and 15% 
decrease in cancer detection and recall rates (FPs) respectively were demonstrated 
[28-31]. Such promising results were reported for women regardless of their age and 
density status and therefore DBT may be the future of screening strategy. However, 
radiation dose is doubled when DBT is used along with mammography and therefore 
the reconstructed synthesised image (C-view) has gained approval in clinical use to 
replace conventional mammograms [32]. Preliminary work with C-views (with DBT) 
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show the same FPs and cancer detection as using DBT along with mammography 
and therefore it may be a possible alternative to mammography. 
 
It is also important to note that unlike mammography, no alternative screening 
modality is proven to reduce mortality despite the fact that breast ultrasound (US) 
and magnetic resonance imaging (MRI) have greater sensitivity in detecting and 
characterising breast lesions especially for dense breasts [33-35]. Currently, these 
modalities are utilised as supplementary screening tools in addition to 
mammography for women with high breast density and elevated risk for breast 
cancer. Breast US and MRI result in increased cancer detection rates [34] but 
concomitant increases in FPs have been reported [35, 36]. In addition, inherent 
limitations of these modalities such as operator dependency and longer 
interpretation time for US and technical and cost issues for MRI restrict them for 
mass screening. Therefore, their screening usages remain debatable and they are 
used routinely in clinical practice for investigating extent of disease and additional 
evaluation of breast abnormalities [37, 38]. Several other emerging techniques have 
been developed, which includes contrast-enhanced mammography (CEM), positron 
emission mammography (PEM), CT dedicated for breast and CT laser 
mammography. For example, CEM and PEM are used to overcome some of the 
limitations of MRI techniques, however none of these approaches have gained 
widespread use in clinical practices and particularly in screening purposes. 
Currently, these techniques are under development with the hope of increasing 
cancer detection rates. Mammography is therefore more likely to remain the primary 
screening method in near future even though it is imperfect test [39].   
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1.2.2 Breast cancer screening in developing countries 
 
While the introduction of MS has transformed breast cancer detection in developed 
countries, its introduction in developing countries continues to be delayed. As 
outlined by the World Health Organisation (WHO), [40] high cancer prevalence is the 
most important prerequisite for implementing an effective screening strategy, which 
guides low incidence countries to avoid adopting MS nationwide. MS is therefore not 
universally introduced and locally established programs for early detection remain in 
most of the developing countries. Clinical breast examination (CBE) is the first 
recommendation for breast screening however this approach is only useful when 
used along with mammography [41, 42]. In terms of cost effectiveness, CBE is also 
often considered where mammographic resources are limited [43]. In addition to 
CBE, breast self-exam (BSE) is another alternative for screening and continues to be 
used amongst low-income countries. However, to date, insufficient clinical benefit 
has been shown for BSE and CBE in screening settings following large randomised 
control trials conducted in China [44], Japan [45] and India [46]. Nonetheless, 
although no mortality benefits were reported to be associated with SBE and CBE, 
their positive impact on detecting early breast cancer should not be disregarded and 
therefore can be considered in resource-limited settings.  
 
1.3  Difficulties in breast cancer detection   
 
If breast cancer is detected in its early stage of development, survival is much better 
than when detected at later stages [47]. It is therefore important to detect preclinical 
breast cancer, however, it remains very difficult due to its complex and multifactorial 
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nature. Such challenges often appear to be associated with limitations of 
mammography since it is the main imaging modality. In fact, its sensitivity is linked to 
numerous factors such as the characteristics of patient and malignant lesion and as 
well as the ability of the interpreting radiologists. Any of these factors can be at least 
in part responsible for missed cancers and thereby it may not be surprising that up to 
30% of cancers are reported to be missing during screening mammography [48, 49]. 
Among all contributing factors, radiologists’ interpretive performance and 
mammographic breast composition arguably play the most critical roles in diagnostic 
accuracy and will be examined in the following two sub-sections. It should be noted 
that other factors including image quality regarding used techniques (positioning and 
exposure parameters) remain on important considerations when diagnostic accuracy 
discussed.  
 
1.3.1 Interpretive performance of radiologists 
 
Mammographic interpretation is not a straightforward task for radiologists. Therefore, 
diagnostic accuracy varies greatly between radiologists and substantially contributes 
to overall mammographic error. Malignant features can be missed due to ability of 
radiologists to properly interpret the image. Influential factors for such mistakes can 
be summarised into four main groupings. First, technical aspects including poor 
positioning, inadequate compression and exposure parameters can have the 
potential to alter reader performance [50-52]. If these are not optimised and, 
visualisation of all the relevant breast tissue may not be apparent, resulting in limited 
or no lesion visibility. Second, morphological features of the malignancy (lesion type 
and size) may reduce reader performance; particularly, it is well known that 
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architectural distortion and stellate lesions are amongst the most difficult lesion 
appearances for radiologists [53-55]. Third, reader performance may also be 
reduced with characteristics related to the reader itself: eye performance and its 
capability of detecting low contrast details, annual interpretive volume, experience in 
reading mammograms and training in breast imaging [56-58]. However, it should be 
noted that the literature has demonstrated inconsistent findings specifically for 
interpretive volume and number of mammograms read per year [59-61]. Finally, 
some part of variability can be explained with patient related factors such as body 
habitus and breast composition.  
 
To reduce mammographic mistakes, understanding the nature and cause of the 
error should be important. In radiology, errors are classified into three types. First, 
when radiologist fails to continue to search for subsequent abnormalities (real 
lesions in question) after identifying an initial abnormality such as benign features. 
This type of error is called satisfaction of search (SOS) and it occurs frequently 
(42%) in mammography [62, 63]. In addition, according to visual search studies [64, 
65], regardless of the cancerous nature of a lesion, initial detection of this 
abnormality may suppress the subsequent discovery of another abnormality thereby 
causing SOS effect. Second, perceptual errors account for approximately 32% of 
mistakes and occur when the abnormality is not seen in the initial interpretation but 
can be recognised retrospectively [66-68]. Several factors can cause such errors, 
including reader fatigue and inattention, distractors (cell phone, emails) and poor 
visibility of lesions [62, 69, 70]. Third, cognitive errors (decision-making) occur when 
radiologists detect the abnormality but do not understood its importance and thereby 
misdiagnose [69]. Factors associated with decision-making errors have been 
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reported: lack of knowledge of mammographic findings, misleading clinical 
information, absence of prior images and reading room environment [68, 71].   
 
Varying strategies have been proposed to minimise mammographic errors. Despite 
being costly, some countries such as Australia, Singapore and European countries 
such as England and Denmark have implemented a double reading strategy, 
however its benefits are found to be contradictory. Considering possible variabilities 
in perceptual and cognitive abilities between interpreting radiologists, double reading 
initiatives aim to increase cancer detection however some authors have showed 
supporting findings [72, 73] whilst others did not [74, 75].  Computer aided systems 
(CAD) are another potential step to overcome reader limitations around detection 
and diagnostic tasks (that is differentiation between malignant or benign) for 
radiologists [76]. Nonetheless, findings from studies that looked at CAD systems are 
not always supportive of their usage in clinical practice due to their high FP rates [77-
80]. In addition, to eliminate the potential impacts of external factors including 
technical quality, display tools and room environment on reader performance, it is 
important to optimise these parameters to assist radiologists’ reporting [63].  
 
Educational interventions are often found to be an effective strategy to improve 
reader performance [81-83]. The advantages of training were also confirmed by a 
recent randomised controlled trial, which demonstrated improved interpretive 
performances for radiologists who used DVD teaching cases [82]. Several training 
platforms have been implemented successfully, which provide self-auditing and 
subsequent feedback, such as: Breast Screen Reader Assessment Strategy 
(BREAST) in Australia and New-Zealand (NZ) and PERsonal perFORmance in 
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Mammographic Screening (PERFORMS) in the UK [82-84]. The importance of self-
audit and subsequent feedback is to provide individual readers the opportunity to 
identify corrective needs in timely manner. For example, BREAST has involved 80% 
of breast screening radiologists in Australia and NZ since its introduction in 2011 and 
demonstrated that all accuracy measures have been improved such as lesion 
sensitivity by 28% between 2011 and 2013 [82]. BREAST is now accessible 
worldwide with radiologists already participating from countries such as Singapore, 
Vietnam, Italy, Jordan and Iran [85].  
 
1.3.2 Mammographic breast density  
 
Mammographic breast density (MD) is a very important feature that affects how 
easily cancers are detected. MD refers to the dominant appearance of glandular 
tissues (epithelial cells of ductal and lobular system) along with fibrous stromal 
particles (connective tissue, collagen and vessels) as opposed to the fatty 
component of breasts. It is well established that increased MD reduces the visibility 
of abnormal lesions and thereby reduces the sensitivity of mammography, known as 
the “masking effect” [86-88]. However, how much of dense tissue will obscure 
lesions is a matter of discussion and therefore accurate estimation of dense tissue is 
critical. On the other hand, high MD has been linked to an increased risk for 
development of breast cancer with odds ratio as high as 6.0 being reported [89-91]. 
It is also known that breast tissue is normally dense at younger ages and reduces as 
women ages. However, there is a possibility of older women being presented with 
high MD, as breast density relies greatly on genetics, hormone and parity status, 
lactation history and hormone replacement therapy [92, 93]. Considering the facts, it 
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may be argued that it is important to identify women who would not benefit from MS, 
so that alternative screening approaches can be recommended.  
 
In the clinical practice, radiologists evaluate and describe breast density visually 
according to the Breast Imaging Reporting and Data System (BI-RADS, 5th edition), 
produced by American College of Radiology (ACR) and classify breasts into one of 
four categories: A- almost entirely fatty, B- scattered fibroglandular densities, C-
heterogeneous density, which may obscure detection of small masses and D- 
extremely dense breast which lowers mammographic sensitivity. Among radiologists, 
BI-RADS is popular method of assessing breast density and it has been used for 
long period. In the latest edition (2013), emphasis is given to how likely abnormal 
features would be obscured by dense tissue based on the confidence of interpreting 
radiologists [94]. Despite being used widely among radiologists, BI-RADS 
assessment use remains controversial due to high variability between readers [95]. 
However, little is known about radiologists’ behaviour when facing different 
parenchymal pattern [88]. The importance of understanding parenchymal patterns 
was first recognised by John Wolfe in 1976 [96] and later by Lazlo Tabar in 1997 
[97]. However, density values failed to gain clinical significance due to the subjective 
nature of assessment. Consequently, quantitative and more sophisticated 
approaches have been proposed but their usage in clinical practice remains limited. 
Even though such quantifiable methods have potential to overcome reader 
limitations, its introduction to everyday clinical practice requires at least consistency 
across different vendors and feasibility to be integrated into clinical systems [98].  
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Figure 1. Mammograms of normal breast density, BI-RADS 2013 lexicon [95]. A-
almost entirely fatty, B-scattered fibroglandular densities, C-heterogeneously dense, 
which may obscure detection of small masses, D-extremely dense which lowers 
mammographic sensitivity. 
 
1.4  Deficiencies in the literature 
 
To date, the literature around breast cancer presentations is very limited in Mongolia. 
In total, there appears to be five works which have investigated some aspects of 
breast cancer in the country. Troisi et all published two studies focusing on the low 
incidence of breast cancer in Mongolia and its possible explanations. In 2012, Troisi 
et all first showed the relatively low incidence of breast cancer in Mongolia and 
hypothesised that this may be possibly linked to the unique diet (high consumption of 
meat and dairy products) [14], although it seems to be contrary to the existing 
evidence of possible association between high intake of animal fat and breast cancer 
risk [99, 100]. Therefore other dietary factors such as high consumption of tea, 
vitamin D and folate level along with the high consumption of fat may contribute to 
the low incidence of breast cancer for Mongolian women that need to be explored 
[14]. They also indicated that with only access to one mammographic unit at the 
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NCC, a large proportion of breast cancers may not be diagnosed and this may 
possibly contribute to the low incidence numbers in Mongolia. Also due to the origin 
of cancer site being difficult to identify when advanced stage cancers with multiple 
distant metastasis present, a significant number of such cancers may not have been 
recognised as being primary breast cancer. However, number of cancers with 
unknown origin was unclear in this study [14] and thus it is difficult to link low 
incidence of breast cancer to missed diagnoses. The last suggestion from this study 
was the possibility of unregistered cancer cases and this is especially true for rural 
areas where breast cancer may fail to be registered.  
 
In 2014, Troisi et all further hypothesised that the hormonal status of Mongolian 
women may play a role in relatively low incidence and demonstrated that these 
women had substantially higher level of circulating oestradiol and progesterone and 
lower in testosterone than British women [15]. It is interesting to note that high 
oestradiol and progesterone levels are often linked to high risks of breast cancer 
among Western women [101], but not for Mongolian women and thereby, the 
authors suggested that unusual combination of lower level of testosterone along with 
high progesterone may provide protective effect women in low incidence settings 
[15].  
 
The third study [20] was a national study investigating survival status of breast 
cancer in Mongolia involving more than 1000 breast carcinoma cases between 2003 
and 2012. According to these findings, only 25% of patients in Mongolia were 
diagnosed during the early stages of breast cancer, which highlighted the urgent 
need for early detection programs in Mongolia. The last two studies were also 
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nationally-based and the unpublished outputs from PhD theses. The first by Dr 
Enkhtur (2009), focused on genetic and hormonal factors and demonstrated some 
interesting findings such as early menarche and nulliparity as possible risk factors for 
breast cancer. The second (2009) by Dr Ramish investigated mammographic 
features of breast cancer for Mongolian women. He looked at breast composition 
using Wolfe’s grades of parenchymal pattern, involving 150 healthy women and 
concluded that majority of women had low (P1) and high (P2) density breast, which 
accounted for 40% and 27% of women retrospectively. Highest density (DY) pattern 
accounted for 12% and lowest density (N1) for 21%. However, this study has several 
limitations including a small sample size. More importantly, reliability of the density 
assessment seems questionable since number of readers and agreement between 
readers were unknown throughout the study.   
 
Despite the above findings, the status of breast cancer continues to be less 
understood in Mongolia compared with many other countries. Nonetheless, all these 
studies demonstrated that incidence of breast cancer is on the rise.  More 
importantly, it is now very clear that advanced breast cancers are not uncommon in 
the country. In Mongolia, lack of breast screening program plays a role in late 
diagnosis of breast carcinomas, however it is possible that other important causal 
factors such as breast cancer awareness and mammographic accuracy remain 
unknown. In particular, mammographic diagnostic accuracy has never been 
investigated and MD characteristics are less clear in the country, which are key 
determinants of mammographic sensitivity. Also there is lack of data on radiologists’ 
level of diagnostic accuracy and without this information, it is unlikely that an 
effective screening approach will be introduced in the near future in Mongolia. In 
 
 
18 
view of these knowledge deficiencies, the current thesis was focused to specifically 
identify the radiologists’ accuracy in reading mammograms and examine distribution 
of MD for women in Mongolia. By examining these issues, important data will be 
available to health care professionals, researchers and policy makers to initiate rapid 
discussion around implementation of the most effective Mongolian-relevant 
strategies to minimise the impact of the breast cancer.  
 
1.5  Aims and objectives  
 
The aim of this thesis is to provide information that would help in establishing a 
national screening program in Mongolia by exploring the interpretive accuracy of 
radiologists in reading mammograms and characterising MD in Mongolia. The 
objectives are:  
 
1) To publish a literature review in an international peer-reviewed journal to 
identify the overall status of breast cancer in Mongolia in terms of incidence, 
mortality, survival features along with information of risk factors and breast 
cancer screening; 
 
2) To investigate radiologists’ accuracy in reading screening mammograms 
using two different test-sets with deliberately different levels of difficulty; 
 
3) To examine the distribution of MD for Mongolian women and its relationship 
with age, body mass index and area of residency using the density categories 
of BI-RADS 5th edition. 
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1.6  Thesis structure 
 
The thesis includes six chapters and each chapter was written to be read 
independently. Published papers of candidature are allowed to be included in the 
thesis by the University of Sydney. The work is arranged in the following manner: 
 
Chapter 1 (the present chapter) provides an overview of the thesis framework and 
its purposes; 
 
Chapter 2 demonstrates a detailed literature review on descriptive epidemiology of 
breast cancer for Mongolian women, which includes incidence, mortality and survival 
features along with information for risk factors and breast cancer screening. These 
data were presented in comparison with women in Asian and Western countries. 
This chapter was published in Breast Cancer Target and Therapy (a peer reviewed 
journal) as: Demchig, D., C. Mello-Thoms, and P.C. Brennan, “Breast cancer in 
Mongolia: an increasingly important health policy issue.” Breast Cancer : Targets 
and Therapy, 2017. 9: p. 29-38. 
 
Chapter 3 examined the radiologists’ performance using a high difficulty (HD) test-
set with 60 mammograms. This chapter is provisionally accepted in the British 
Journal of Radiology (a peer-reviewed journal); Demchig D, Mello-Thoms C, Lee W, 
Khurelsukh Kh, Ramish A, and P.C Brennan, “Mammographic detection of breast 
cancer in a non-screening country.”  
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Chapter 4 identified the radiologists’ performance using a typical screening (TS) 
test-set with 60 mammograms and compared the findings with the previous results 
acquired from the HD test-set. This chapter was published in Academic Radiology (a 
peer-reveiwed journal) as Demchig D, Mello-Thoms C, Lee W, Khurelsukh Kh, 
Ramish A, and P.C Brennan, “Observer Variability in Breast Cancer Diagnosis 
between Countries with and without Breast Screening.” Acad Radiol, 2018.  
 
Chapter 5 identified the distribution of MD for women in Mongolia. This chapter was 
published in the Asia Pacific Journal of Cancer Prevention (a peer-reviewed journal) 
as Demchig D, Mello-Thoms C, Khurelsukh Kh, Ramish A, and P.C Brennan, 
“Mammographic Appearances in Mongolia: Causal Factors for Varying Densities.” 
Asian Pacific Journal of Cancer Prevention, 2017. 18(9): p. 2425-2430. 
 
Chapter 6 provided a discussion on the significant findings, future directions of the 
research work and conclusion. 
 
A bridging section is inserted at the beginning of each chapter. 
 
Appendices attached in this thesis provide materials used in the studies.  
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Figure 2: Thesis structure flowchart 
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2.2 Bridging section for chapter two 
 
The statistics indicate that breast carcinoma is the highest occurring malignancy 
among women worldwide. However, depending on geographical location and 
economic resources of a country, patient outcomes vary between nations. To date, 
characterization of the disease is well recognized in developed countries supported 
by extensive research studies about: knowledge around risk factors, types of disease 
and women being affected, and treatment and diagnostic status. Based on this 
information, the management and control of breast cancer appear to be well 
maintained among Western countries, where effective breast screening programs 
exist and advanced treatment options are available. Unlike Western countries, 
available data on characteristics of breast cancer are difficult to find in Asia. 
However, we do know some basic features of the disease for women in this region, 
particularly around: epidemiological characteristics (low incidence and high mortality 
rates, younger age at onset), clinical features (high proportion of advanced stages), 
common risk factors such as MD (denser than those noted in the West) and 
molecular subtypes (high proportion of ER negative and HER2 positives) [1-3]  
 
As previously discussed, breast cancer incidence in Mongolia is among the lowest in 
the world but advanced diagnoses are common and the disease may have specific 
features. It should be noted that the low rates of incidence and mortality of breast 
cancer in Mongolia could be due to the traditional lifestyle of Mongolian women such 
as longer duration of breastfeeding, high number of parity and low exposure to the 
consumption of smoking. Based on the available statistics between 2009 and 2013, 
incidence and mortality numbers appear to be increasing but it may not be 
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significant, as natural variations with such small data can exist. However in 
Mongolia, research data is rarely available when compared internationally and 
thereby the status of breast cancer remains less clear.  
 
Located between two large countries, China and Russia, Mongolia has unique and 
diverse socio-cultural and lifestyle features. The country is mostly influenced by 
Russia, since the two countries had a long-lasting, strong relationship of more than 
70 years until 1990, when democracy was introduced to Mongolia [4]. For example, 
until recently, Russian was the most popular language in the country and Soviet 
education was common among Mongolians. As of 1990, the country has opened up 
foreign relations with other countries such as the USA and UK and subsequently 
westernized culture and lifestyles have been introduced. In addition, the country has 
no access to the ocean with continental dominant climate (extremely cold and long 
winter, warm and dry summer) along with a high altitude location. Mongolia is 
therefore very distinct from the rest of Asian countries although geographically 
located in the same continent.  
 
Indeed, Mongolia still relies on hospital care rather than preventative measures. It 
may be of no surprise that the current health system is designed based on the Soviet 
system (bed-based hospitals). To date, inpatient hospitals are still common practice, 
which requires a large healthcare budget [5] and this may contribute to lack of funds 
for other important strategies and policies such as the development of screening 
program when required. With the right policy direction, effective re-allocation of 
health funds is critically important to improve patient outcomes. For example, 
mammographic screening is well established and became a standard clinical 
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practice in Western countries, which subsequently contributed up to 30% of 
reduction in breast cancer mortality [6,7]. However, it should be acknowledged that 
the effectiveness of screening remains debatable due to its potential downwards and 
benefits. In particularly, mammography is less sensitive for women with high-density 
breasts and therefore, alternative screening approaches such as clinical breast 
examination and breast ultrasound has been recommended. However, currently 
limited available data cannot support developing such strategies in Mongolia. But it is 
clear that a more functional approach is needed, since a high proportion of late stage 
diseases presents in the country. It is therefore very important to first determine the 
overall status of breast cancer in Mongolia, since without this information further 
progress is not achievable.  
 
In view of the knowledge deficiencies, the focus of the current literature review is to 
provide an understanding of the overall characteristics of breast cancer in Mongolia 
in terms of incidence, mortality, survival, risk factors and breast screening activities. 
As benchmark, the Mongolian data were compared with Western and Asian 
countries and due to limited literature about breast cancer in Mongolia, sometimes-
local unpublished studies are cited.  
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Abstract: Breast cancer is a leading cause of cancer-related death for women in both developed 
and developing countries. The incidence and mortality of breast cancer in Mongolia, while low 
compared with other counties, has been increasing on an annual basis. In addition, in Mongolia, 
approximately 90% of the patients are diagnosed at a late stage, resulting in high mortality, 
with the majority of individuals diagnosed with breast cancer dying within 5 years of diagnosis. 
Breast cancer screening plays an important role in reducing mortality in Western countries and 
has been adopted by a number of Asian countries; however, no such approach exists in Mon-
golia. In a country of limited resources, implementation of expensive health strategies such as 
screening requires effective allocations of resources and the identification of the most effective 
imaging methods. This requirement relies on recent accurate data; however, at this time, there 
is a paucity of information around breast cancer in Mongolia. Until data around features of the 
disease are available, effective strategies to diagnose breast cancer that recognize the economic 
climate in Mongolia cannot be implemented and the impact of breast cancer is likely to increase.
Keywords: incidence, mortality, breast screening, Mongolia
Data source and material
The data used in this review mainly arose from 2 sources; the Cancer Registry, located 
in the National Cancer Center (NCC) in Mongolia,1 and the International Association of 
Cancer Research (IACR).2 The Cancer Registry in Mongolia was initiated as a hospital-
based registry at the NCC in the early 1960s and has now developed as a population-
based registry,3 where data on incidence and mortality of breast cancer between 2009 
and 2013 are available. All newly diagnosed cancer and death cases along with the 
personal and clinical information are recorded at the primary- and secondary-level 
hospitals and submitted to the Cancer Registry via Health info-2 software.4
The quality of the data in Mongolia is not clear, as data collection relies on certain 
factors such as population coverage and collection method. For example, the limited 
availability of health facilities and trained health professionals in rural areas may result 
in a number of cancer cases not being diagnosed and many deaths not being recorded. 
Also, the comprehensiveness of the data is not well understood since histology and 
morphology records have only become available since 2012.4
Introduction
Breast cancer remains the major health concern since it is the most common cancer 
among women in the world.2,5 The rates in incidence and mortality, however, vary 
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significantly by region. In general, developed nations dem-
onstrate a greater incidence (greater than 80 per 100,000) 
compared with developing countries (less than 30 per 
100,000), although the latter group is currently demonstrat-
ing more rapid increases in incidence.6 Women in low- and 
middle-income countries tend to be diagnosed at late stages 
largely due to lack of available routine mammographic 
screening and breast cancer awareness.7,8 In such low resource 
countries, research data are needed to understand the impact 
and tailoring of limited resources to maximize impacts on 
breast cancer.9–11
Mongolia, with a population of 3 million, is one of the 
fastest developing countries in Asia, but encounters a substan-
tial and unique cancer burden nationwide. While liver cancer 
is almost 4 times higher than the world average, being by far 
the most common cancer among both sexes,3 breast cancer 
is the 5th most common primary cancer among Mongolian 
women with a current rate of 6 per 100,000 women, account-
ing for 6% of all new cases of female cancer.1 Despite these 
low figures, the incidence rate appears to be increasing on an 
annual basis.1,12 Also, since the majority of cancer patients are 
diagnosed at a relatively late stage, the disease has become 
a serious public health issue.13,14
It should be acknowledged from the outset that in Mon-
golia, details on the incidence, nature and mortality around 
breast cancer, along with information on type of women 
affected are limited and without such data, future health poli-
cies or systems around this disease cannot be strategically 
planned or implemented. This review aims to bring together 
the available data and provide an overview of the current 
status of breast cancer epidemiology in Mongolia. The data 
will be presented in the context of what is known about the 
disease in Asian countries and westernized populations.
Breast cancer incidence
While Mongolia has a relatively low breast cancer incidence 
rate, this value has been consistently increasing. An examina-
tion of the annual cancer registry in Mongolia between 2009 
and 2013, which contains some of the most recent breast 
cancer data (Figure 1), demonstrated a substantial increase 
in the breast cancer incidence rate from 3.0 in 2009 to 6.0 in 
2013.1 However, the year on year increase was inconsistent, 
with the most rapid increase of 54% seen in the 2009–2010 
period resulting in incidence rates of 3.0 and 4.6 per 100,000 
in 2009 and 2010, respectively. An increasing trend in breast 
cancer has also been reported earlier by Troisi et al,12 based 
on data between 1998 and 2005 from the IACR and the NCC 
in Mongolia.
As noted in other Asian countries, incidence rates within 
Mongolia vary by geographical regions (Figure 2). For exam-
ple, some rural provinces of Khentii and Bayan-Ulgii have 
considerably higher rates of 10.1 and 11.0/100,000, respec-
tively, compared with the national level at 6.0/100,000,1 and 
it is interesting to note that these provinces are the home 
for most of the ethnic minorities of Mongolia. Such ethnic-
dependent variation in incidence (and presentation) of breast 
cancer has been reported in the neighboring country of 
People’s Republic of China.15 Although the cancer registry is 
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Figure 1 incidence rate of female breast cancer, Mongolia, 2009–2013.
Note: Data from Cancer Registry Data, National Cancer Center, Mongolia, 2009–2013.1
Abbreviation: ASR, age-standardized rate. 
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available for collecting data across the whole of the country, 
data from rural areas may be impacted by limited health facil-
ities, number of professionals and data distributions system 
compared with 3 urban locations in the country – the city of 
Ulaanbaatar (UB) and the larger provinces of Darkhan-Uul 
and Orkhon. A strong relationship between breast cancer 
and age has also been identified among Mongolian women 
with the highest incidence rate of 28.4/100,000 occurring 
among the 50–54 years old compared to 3.7 per 100,000 in 
the 15–39 age group.2 Although the peak age appears to be 
closer to other Asian countries, at least a decade difference 
is noted when compared with westernized states (Figure 3).
Asia in general has a low incidence of breast cancer com-
pared with westernized countries. However, compared with 
Mongolia the disease is still common among Asian women6,16–20 
and with a mean incidence of 29 per 100,000 in 2012, it is the 
most common cancer.2 Also when compared with countries 
such as the US, UK and Australia, the younger median age 
at diagnosis (40–50 years as opposed to 50–60 years) and the 
more progressed stage of the disease when diagnosed in Asia 
are quite different.17–19 However, due to lifestyle and reproduc-
tive changes in Asia, differences from westernized states to 
some extent are diminishing; for example, the incidence rates 
are increasing rapidly in the former, even though in absolute 
terms the rates for the time being remain low.20–22 
In the westernized world, breast cancer is the most 
common cancer among women with a mean incidence of 
90 per 100,000 in 2012.2 It has been observed that while 
age-standardized rates (ASRs) for breast cancer are higher, 
the rates are beginning to stabilize within developed countries 
unlike developing countries where breast cancer is continu-
ing to emerge as an increasingly important health issue.23,24
Breast cancer survival
In Mongolia, data on survival of breast cancer are very 
limited. With the lack of an early detection program and 
limited diagnostic and therapeutic resources, breast cancer 
is diagnosed at late stages, leading to a 5-year survival rate 
of 57% that is considerably lower than that described in 
other countries as highlighted by the recent global study 
based on the data between 2005 and 2009.25 Similar find-
ings were shown in the report from the NCC for the period 
2003–2013, which found that the average survival time for 
Mongolian patients with breast cancer was 3.2 years.14 Also 
in Mongolia, 88.7% of women diagnosed with breast cancer 
are reported to die from the disease within 5 years,14 which 
is significantly higher than westernized states where 5-year 
survival is closer to 90%. The limited access to health ser-
vices in remote areas may play a role in delay of diagnosis 
resulting in poor survival outcome.
As a result of the advanced presentation of disease, the 
majority of breast cancer patients have radical mastectomy 
with axillary dissection combined with radiotherapy and 
chemotherapy, leading to a worse survival outcome compared 
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Figure 2 Age-standardized incidence rate by province, Mongolia, 2013.
Note: Data from Cancer Registry Data, National Cancer Center, Mongolia, 2009–2013.1
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with the more developed treatments adopted elsewhere. Since 
early stage breast cancer is less frequent, the implementation 
of breast conserving surgery along with radiotherapy has 
only been conducted on a small proportion of patients. The 
use of radiation therapy remains low in Mongolia partially 
due to shortage of radiation oncologist and technologists. In 
addition, to treatment options, breast cancer survival can also 
be affected by other factors such as lifestyle, environmen-
tal, cultural and socioeconomic;26 however, information on 
these factors and their association with survival is not well 
understood in Mongolia.
In Asia, inconsistency of early detection programs and 
the varying levels of access to appropriate treatment have led 
to the survival rates varying considerably across the region. 
In Japan, Republic of Korea and People’s Republic of China, 
for example, 5-year survival rates of 85%, 83% and 82%, 
respectively, have been reported for invasive cancer cases 
during 2005–2009.25 More similar to Mongolia, survival 
rate is reported to be lower in Malaysia and India, where 
the rate is closer to 68% and 60%, respectively.25 In addi-
tion, the majority of breast cancer patients from developing 
countries in Asia continue to be diagnosed at a relatively late 
stage and over 50% of all managed patients present with 
locally advanced cancer at the time of diagnosis.21,27,28 It is 
important to note that even when detection and treatment 
opportunities exist, other factors, including estrogen receptor 
(ER) status, preexisting chronic disease and ethnicity impact 
upon variation in survival. For example, ER-negative cancers 
are more commonly reported among Asian women, which 
is associated with poor prognosis.19
The introduction of mammogaphic screening in western-
ized states highlights a potential way forward for Mongolia 
and other developing Asian states. Screening aimed at 
asymptomatic patients has led to marked improvements in 
overall survival. For example, In 1991, screening was intro-
duced in Australia and 5-year survival rate was shown to 
increase from 72% to 89% between the periods 1982–1995 
and 2006–2010.29 However, the impact of changes in preva-
lence of risk factors and advances in diagnosis and treatment 
on favorable survival outcome cannot be ruled out. Such 
factors impact on stage of diagnosis and treatment. The 
former is a critically important determinant of survival, 
particularly regarding tumor size and the involvement of 
lymph nodes.30,31
Breast cancer mortality
There is a paucity of quality data around mortality rates 
in Mongolia with some rural areas having no mortality 
data. A relatively recent national study13 demonstrated 
that 93.4% of the Mongolian women with breast cancer 
were diagnosed at advanced stages (Figure 4). The data 
that are available indicate that breast cancer is the 8th 
most common cause of cancer-related death in the country 
with age-standardized mortality rate of 2.7 per 100,000 in 
2012.1 Comparisons with Asian and Westernized countries 
are demonstrated in Table 1. Similar to other developing 
Asian countries, mortality rates (and incidence numbers) 
are predicted to increase due to adoption of westernized 
lifestyle and recent increased detection and treatment 
facilities in Mongolia.
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Although the ASRs for breast cancer in Mongolia 
historically have been consistent, a recent important 
increase has been described by recent national mortality 
data between 2009 and 2013 (Figure 5) where the rate was 
almost doubled from 1.4/100,000 in 2009 to 2.7/100,000 
in 2012.1 Interestingly, more than half of the deaths from 
breast cancer were registered in the capital city of UB 
in 2013. This figure is likely to be explained at least in 
part by population distributions since almost 50% of 
the Mongolian people live in UB32 and also by an urban 
lifestyle, which reflects westernized activities. Following 
the 2009–2012 increase, the mortality rate was declined 
to 1.6/100,000 in 2013. The explanation for this unusual 
change to the trend is unclear and may reflect incomplete 
data coverage.
Regional mortality variations in Mongolia, however, 
are not confined to the capital. Outside UB, variation in 
mortality rates is also evident with numbers being higher 
in rural provinces such as Bayan-Ölgii (4.4) and Dornod 
(4.0), while being lower in other regions such as Khuvsgul 
(0.8) (Figure 6).1 While inconsistent registry data may have 
contributed to these recorded variations, the stage of dis-
ease presentation is likely to be linked to these geographic 
variations.
While the rates are decreasing in many westernized 
nations,29,33,34 mortality rates continue to increase in Asian 
countries, aligning with rapid increases in incidence of 
breast cancer.19,22 In Asia, higher mortality rates are often 
observed in less developed countries despite these countries 
having low incidence rates.18,28,35 A variety of explanations 
have been proposed for these regional-dependent patterns 
around culture, socioeconomic factor, geographical isola-
tion, inadequate diagnostic equipment and poor treatment 
facilities; however, a consistent casual parameter is delayed 
presentation of the disease.18,22,36
In developed countries, breast cancer is the 2nd leading 
cause of cancer-related mortality after lung cancer, result-
ing in 198,000 deaths (15.4% of all cancer deaths) in 2012.2 
Mortality rates for breast cancer have steadily declined in 
most westernized countries;37–40 however, based on 2012 data, 
globally it is estimated that more than half million women 
will die from this disease annually, highlighting that breast 
cancer is not only the disease of developed countries.
Breast screening
Currently, in Mongolia, there is no population-based 
breast cancer screening; instead in 2010, guidelines were 
established for the prevention and management of the 
disease. As outlined in the guidelines, mammography is 
not  recommended for early detection due to the relatively 
low incidence rates, limited resources for equipment and 
sparsely distributed populations in Mongolia.41 Therefore, 
clinical examination is the front line tool used for early 
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Figure 4 Breast cancer by stage, Mongolia.
Table 1 estimated breast cancer incidence and mortality by 
country, 2012
Countries Incidence Mortality
Number ASR 
(world)
Number ASR 
(world)
Mongolia 125 9.4 50 1.6
Asia 650,983 29.1 231,013 6.4
westernized countries* 127,016 89.5 26,906 7.3
Notes: The rates are age-standardized per 100,000 female population. *North 
America, western and Northern europe, Australia/New Zealand. Data from 
GLOBOCAN 2012.2
Abbreviation: ASR, age-standardized rate.
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detection of the disease, and all suspected cases in local 
hospitals refer to the NCC for further diagnostic evaluation. 
However, this screening approach is having a limited impact, 
with only 1 in 3 women reporting breast self-assessment and 
only 3.2% and 1.7% undergoing clinical breast examination 
and mammography, respectively, as reported in a recent 
WHO review.42
In recent years, the importance of early detection for 
breast cancer has become a serious issue in Mongolia due to 
increasing reports of late presentation and rapid increase in 
incidence of the disease.12–14 Since mammographic facilities 
have been established in both public and private hospitals 
in Mongolia, implementation of breast screening could be 
an effective approach to detect the disease at early stages. 
Although mammographic screening reduces mortality in 
westernized countries, there is no evidence that systems 
used elsewhere would be effective in Mongolia. Therefore, 
more investigations around breast types and breast cancer 
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presentations in Mongolia need to be carried out so that a 
country-specific solution can be found.
In Asia, compared with the Western nations, breast cancer 
screening is not so widespread. The effectiveness of mam-
mographic screening in Asia is the subject of debate due 
to the low incidence of breast cancer across the region, the 
prevalence of smaller breasts and denser breast parenchyma 
among Asian women.43,44 Nonetheless, some Asian countries 
have adopted mammography for mass screening, such as Sin-
gapore, Japan and Taiwan, where some favorable outcomes 
have been reported.45–48 In Singapore for example (the first 
Asian country to introduce screening for 50–69 years old in 
2002), the overall invasive cancer detection rate was reported 
to be 7.92 per 1000 women screened during 2002–2009 and 
a 12% increased rate of early stage cancers was recorded 
compared with prescreening period (before 2001).48
In developed countries, breast screening with mammog-
raphy is a well-established approach for the early detection 
of breast cancer and many experts agree that the benefit of 
mammography outweighs the harms. In particular, mam-
mography is more accurate in older women than in young 
women.49,50 The overall impact of screening is debated with 
reported reductions in mortality from 15% to 58%.50–56
Risk factor
The causes for breast cancer are not fully understood but 
women with certain risk factors are more likely to develop 
the disease than others. In Mongolia, the risk factors associ-
ated with breast cancer are understudied. The only available 
case-control study13 involved 522 breast cancer patients and 
was locally published in 2009. Similar to other countries, 
this limited evidence proposes the following risk factors: 
reproductive factors including early menarche, irregular 
menstrual cycles, nulliparity and obesity; induced abortion, 
which was aligned with a recent Chinese meta-analysis;57 
and various disease states including ovarian chronic inflam-
mation and cysts and uterine fibroids.13 It is also interesting 
to note that ethnic minority groups are expected to have low 
rates of incidence and mortality since these women gener-
ally adhere to more traditional lifestyles compared with their 
westernized counterparts; however, the opposite pattern was 
observed in Mongolia, which suggests a uniqueness around 
genetic and risk factors. While the aforementioned factors 
have been shown to be relevant to Mongolia, other important 
parameters reported for other countries such as family history, 
lifestyle factors and hormone replacement treatment (HRT) 
are currently poorly understood in Mongolia.
Current knowledge regarding breast presentation 
remains poor, which demands a better understanding of 
this disease among Mongolian women. For example, mam-
mographic breast density has been shown to be one of the 
most important risk factors in westernized populations but 
nothing is known around this feature among Mongolian 
women. Westernized women with high density have been 
shown to have 4- to 6-fold increased lifetime risk of breast 
cancer.58–61 This is a feature that can be assessed from 
mammographic examinations and while mammography 
occurs in Mongolia, little data are gathered on density 
distributions, particularly across ethnicity, age, body mass 
index and menopausal status. The absence of information is 
not the case across Asia; for example in China, breasts are 
known to be fattier than in American women in older age 
but denser in young age.62 The importance of understanding 
this feature for identifying risk and indeed for determining 
the optimal method of diagnostic imaging is emphasized 
so that prevention, early detection and intervention of the 
disease can be facilitated.
In Asia, while the prevalence and distribution of risk fac-
tors among Asian women vary between countries and stud-
ies, some common features have been noted in  westernized 
studies.19,63–66 A recent Asian meta-analysis summarized 
that more than 3 abortions, family history, late age at first 
live birth (over 30 years old), smoking, no breastfeeding, 
alcohol consumption and longer usage of HRT are associ-
ated with breast cancer among Asian women.67 Other risk 
factors reported among these women include body fat, 
which reduces and increases the risk of breast cancer in 
premenopausal and postmenopausal women, respectively.68,69 
Uniquely to this region, however, a higher intake of soy food 
with their associated protective effect for breast cancer has 
been reported among Asian women,70,71 and in China, con-
sumption of green tea was reported to be associated with 
risk of breast cancer,72 whereas this was not observed among 
Japanese women.73
In developed countries, certain lifestyle activities, west-
ernized diets, high socioeconomic status, physical inactivity 
and obesity are reported to be associated with breast cancer 
risk in these regions.74–76 For example, a European cohort 
study revealed that an increased risk of 31% for breast 
cancer is strongly associated with obesity among postmeno-
pausal women.76 Family history and gene mutations such 
as BRCA1 and BRCA2 are also well known, established 
risk factors.77–81 In general, hormonal factors are different 
in prevalence between breast cancer subtypes; however, 
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hormone  receptor-positive tumors were consistently being 
reported among Western women.82,83 Westernized women 
also tend to have shorter breastfeeding period and low par-
ity compared with Asian women, resulting in high risk for 
developing breast cancer.84,85
In summary, what is distinct about 
Mongolia?
With the limited available data, this review is the first 
attempt to describe the current situation of breast cancer 
in Mongolia while investigating different aspects of the 
disease. It is evident that breast cancer incidence rate in 
Mongolia is among the lowest in the world and there are 
several possible explanations that have been considered 
in the above sections and relate to lifestyle, health policy 
and quality of registry data. With regard to lifestyle, 
reproductive activities such as longer breast feeding86 and 
higher number of full-term pregnancies probably play a 
significant role, and as described within the only peer-
reviewed publication12 on the topic, dietary habits around 
high-level consumption of tea, meat and dairy product 
may also be key. However, absence of a breast screening 
program must also be a contributory factor particularly 
since it is evident that rates of breast cancer have increased 
in those Asian countries that have recently introduced for-
mal screening programs.48,87 Finally, reliability of cancer 
registry data cannot be excluded as incomplete data exist. 
Until screening procedures are formalized and accurate 
registry data become available, the importance of breast 
cancer to Mongolia cannot be fully appreciated. What is 
appreciated is that late disease presentation, poor survival 
and high mortality demand a coordinated effort between 
researchers, clinicians and health strategists to ensure that 
Mongolian women do not continue to suffer poorer health 
outcomes compared with their neighbors and westernized 
counterparts.
Conclusion
While breast cancer incidence is low in Mongolia compared 
with other Asian countries and westernized states, incidence 
rates are gradually increasing. Early detection with optimal 
imaging methods may be a key to minimizing the impact of 
this disease on Mongolian women; however, not enough is 
known about the type of cancer being presented, the regional 
distribution of the disease and the type of women most 
effected, which is needed to facilitate allocation of limited 
resources.
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3.2 Bridging section for chapter three  
 
Breast carcinomas have a fairly good prognosis if detected at their early phase of 
development [1]. Mammographic screening, amongst all approaches for early 
detection (breast self-exam and physical examinations) has proven to reduce death 
rates from the disease [2, 3]. Therefore, it is recommended frequently and well 
established in Western countries. But its introduction to Asian countries remains 
controversial due to its limited sensitivity for women in their 40s (peak ages for 
breast cancer in Asia) and as well as lack of data on cost effectiveness [4]. 
Nonetheless, in some wealthy Asian countries, where breast screening is available, 
the proportion of early stage diagnoses (Stage I and II) is reported to be closer to 
Western countries such as 60% in South Korea [5] and 70% in Singapore [6]. In 
contrast, advanced diagnoses are very common among less developed Asian 
countries such as India and Vietnam, where breast screening has not been 
introduced yet [7, 8]. Therefore, it can be understood that establishing screening 
approaches with mammography may have the potential to maximize patient benefits 
for developing countries including Mongolia. Although very affordable approaches for 
early detection of breast cancer are desirable in these nations, no such methods 
currently have been reported to be superior to mammography in terms of mass 
screening. Because of this fact, mammography will likely to remain the front-line tool 
for early detection.  
As discussed in the literature review (Chapter 2), breast cancer in Mongolia is an 
important health issue. Its delayed diagnosis is common with more than 90% 
patients at an advanced stage [9] compared with 30% in Australia [10]. As noted with 
other nations in the same region, lack of diagnostic and treatment resources, lack of 
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awareness and limited access to the resources can contribute to these delayed 
diagnoses [11, 12]. Currently in Mongolia, nationwide screening has not been 
introduced and mammography is used in diagnostic settings. However, some of the 
private medical centers in Mongolia have recently initiated screening protocols for 
women who self-request to be screened. Whatever the reason for mammography, 
the challenge is that its performance depends on multiple factors such as patient 
age, image quality, breast density status and reporting ability of radiologists. In 
particularly, early diagnosis and better patient outcome is heavily reliant on accurate 
radiologists’ interpretation of breast images.  
Although breast cancer incidence remains low in Mongolia, it has been consistently 
increasing [13], which highlights a need to focus attention and resources toward 
optimized diagnostic strategies. Additionally, reproductive and lifestyle behavior of 
Mongolian women have shifted to Westernized styles in recent years and thereby it 
can be predicted that increases in incidence are likely to continue. To initiate any 
early detection program, it is important to determine status of diagnostic accuracy. 
Since the introduction of the first mammographic unit at the National Cancer Center 
in 1996 (replaced with digital technology in 2013) [14], breast cancer diagnoses have 
improved in Mongolia however; the diagnostic efficacy of mammography is unknown. 
Identifying the level of diagnostic accuracy is therefore critical to improving the 
quality of breast cancer diagnoses. The current research was therefore conducted to 
establish radiologists’ diagnostic accuracy when reading mammograms using high 
difficulty screening images collected from Australian women, for which we had 
benchmark performance measures from Australian and New Zealand radiologists. In 
this study, we used a research design and method validated by numerous previous 
studies focusing on observer performance in mammography [15-18].  
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Considering the possible variations in breast morphology between ethnic groups, 
using mammograms of Australian women may raise a question on appropriateness 
of testing performance of Mongolian radiologists. However, radiologists are trained 
for interpreting variety of breast morphology (breast density) and therefore, image 
appearances could not have a big impact on reader accuracy. To appropriately test 
the diagnostic accuracy of the local readers, it is crucial to include Mongolian 
mammograms into the test-set, which would have potential to provide meaningful 
information regarding radiologists’ accuracy. However, to meet the test-set criteria, 
breast cancer cases should be biopsy proven with early imaging findings, whilst 
normal images are required to be normal by radiologists, which should be confirmed 
with follow-up examinations. Compared with Australia, collecting such types of 
cancer images from Mongolia is extremely challenging and therefore we were unable 
to conduct this part. This is mostly due to lack of radiology and pathology reports, 
which are not recorded and stored at the hospital systems.   
In addition, using the high-difficulty images for novice readers (Mongolian 
radiologists) may be questionable but breast radiologists should have the ability to 
report any types of mammograms regardless of its difficulty as long as they have 
high technically quality. The current test-set is also the standard images to test 
reader performance in Australia and New Zealand and therefore using these images 
in the present study should reasonably be valid. The radiologists in this study were 
the readers who involves in reporting breast images in Mongolia and Australia. Since 
the current work was the first study on radiologists’ performance in reading 
mammograms in Mongolia, we did not have preliminary results to calculate the 
sample size and therefore power analysis was not feasible.  
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INTRODUCTION
The burden of breast cancer remains high in low-income 
countries. For example, 5year survival rate is approximately 
90% in developed countries, but this figure is reported to 
be around 60% in less developed nations in the Asia Pacific 
region1 and late stage at detection is a key contributory 
agent.2,3 Although multiple factors are linked to delayed 
diagnosis, advanced disease presentation suggests that 
diagnostic efficacy must be improved. Nonetheless, little 
attention or resources have been directed to this topic, 
and it is unclear whether it is patient knowledge, disease 
type, health policy or radiology efficacy that are responsible 
for disease diagnosis at such a late stage. Until more data 
around each of these potential causal factors are provided, 
effective allocation of funding and subsequent successful 
interventions cannot be initiated.
Currently, mammography is the only screening modality that 
is proven to reduce mortality from breast cancer, however, 
many countries still do not have a screening program, 
which is mostly due to lack of financial resources.4,5 None-
theless, opportunistic screening approaches such as private 
or hospital-based screening have been implemented, yet 
their diagnostic efficacy is unclear. Interpreting mammo-
grams, especially screening mammograms is a challenging 
task and prone to diagnostic error, where incorrect, 
missed or delayed diagnosis are not uncommon.6–9 Indeed 
among all imaging modalities, mammography is the most 
common focus for medical lawsuits against radiologists in 
the USA.6,10 Whilst the reasons for this are multifactorial,11 
perceptual and interpretive factors are critically important, 
and these largely depends on the radiologists’ ability to 
interact effectively with the images being reported.12 On 
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Objective: To compare the diagnostic accuracy between 
radiologists' from a country with and without breast 
cancer screening. 
Methods: All participating radiologists gave informed 
consent. A test-set involving 60 mammographic cases 
(20 cancer and 40 non-cancer) were read by 11 radi-
ologists from a non-screening (NS) country during a 
workshop in July 2016. 52 radiologists from a screening 
country read the same test-set at the Royal Australian 
and New Zealand College of Radiologists' meetings in 
July 2015. The screening radiologists were classified 
into two groups: those with less than or equal to 5 years 
of experience; those with more than 5 years of experi-
ence, and each group was compared to the group of NS 
radiologists. A Kruskal–Wallis test followed by post-hoc 
multiple comparisons test were used to compare meas-
ures of diagnostic accuracy among the reader groups. 
Results: The diagnostic accuracy of the NS radiol-
ogists was significantly lower in terms of sensitivity 
[mean = 54.0; 95% confidence interval (CI) (40.0–
67.0)], location sensitivity [mean = 26.0; 95% CI (16.0–
37.0)], receive  roperating characteristic area  under 
curve [mean = 73.0; 95% CI (66.5–81.0)] and Jack-
knifefree-response receiver operating characteristics 
figure-of-merit [mean = 45.0; 95% CI (40.0–50.0)] 
when compared with the less and more experienced 
screening radiologists, whilst no difference in speci-
ficity [mean = 75.0; 95% CI (70.0– 81.0)] was found. No 
significant differences in all measured diagnostic accu-
racy were found between the two groups of screening 
radiologists.
Conclusion: The mammographic performance of a 
group of radiologists from a country without screening 
program was suboptimal compared with radiologists 
from Australia. 
Advances in knowledge: Identifying mammographic 
performance in developing countries is required to opti-
mize breast cancer diagnosis. 
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a positive note, perception and interpretation are modifiable 
and can be enhanced through appropriate education, training 
and experience. Nonetheless, diagnostic accuracy varies widely 
among radiologists,13–15 and in Australia, diagnostic accuracy 
varies from 85 to 95% for sensitivity and 80 to 83% for speci-
ficity.7,16 In the non-screening (NS) country where the NS 
radiologists recruited, these important measures of diagnostic 
accuracy have never been investigated, and until this first step 
happens, diagnostic accuracy cannot be optimized.
Australian breast radiologists have demonstrated better accu-
racy using various parameters when compared to readers from 
other countries having a screening program.15,16 This is often 
explained by differences in reader characteristics such as experi-
ence, practice and training. In the NS country, cancer diagnosis 
relies on diagnostic mammography, with imaging performed 
following a symptomatic concern. In diagnostic mammography, 
the expected prevalence of cancer is higher than in screening 
and presents a very different work process to reading screening 
mammography, where the expectation is that the very large 
majority of females will not have cancer.
In this study, we compared radiologists from a NS country to 
those from a screening country (Australia) using a single popu-
lation test-set, with the aims of identifying possible differences 
in diagnostic accuracy and to determine causal factors linking 
observed measures of diagnostic accuracy with their level of 
expertise.
METHODS AND MATERIALS
Study participants
All radiologists gave informed consent. The study included a 
total of 63 breast radiologists. Details on demographic informa-
tion (age and sex) and professional experience (number of years 
since qualification as a radiologist; number of cases and hours 
reading mammography; fellowship training in breast imaging) 
were self-reported by each reader.
Non-screening radiologists
11 NS radiologists were prospectively recruited and read the cases 
with no time limit during the BREAST (Breastscreen REader 
Assessment STrategy),17 a breast imaging workshop in July 2016 
in Mongolia. These radiologists represented approximately 80% 
of the total number of radiologists involved in mammographic 
reading in the country, where no specific qualifications are 
required to report mammograms. The mean age for the NS was 
32 years old [standard deviation (SD) = 3.7], the mean number 
of years reading mammograms was 1.6 years (SD = 1.9) and the 
mean number of years since being qualified as a radiologist was 
4.0 years (SD = 3.6). Weekly reading volume was less than 4 h for 
all NS radiologists and none of them had completed fellowship 
training in breast imaging.
Screening radiologists
52 screening radiologists read the cases at the Royal Australian 
and New Zealand radiologist’s meetings in September 2012 and 
July 2015. Since all our NS radiologists (see above) had less than 
5 years’ experience reading mammograms, the screen readers 
were divided into two groups: up to 5 years of experience (n = 
27), and more than 5 years of experience (n = 25).
For the less experienced screening radiologists, the mean age was 
46 years old (SD = 10.6) and mean number of years since quali-
fying as a radiologist and working in a screening program were 
6.0 years (SD = 7.0) and 2.2 years (SD = 2.0) respectively. 56% 
had completed fellowship training in breast imaging and 30% 
spent less than 4 h per week reading mammograms.
The mean age for the more experienced screening cohort was 
56 years old (SD = 12) and mean number of years since quali-
fying as a radiologist and working in a screening program were 
19 years (SD = 9.0) and 17 years (SD = 8.7) respectively. 16% had 
completed fellowship training, and 25% of them spent less than 
4 h per week reading mammograms. The characteristics of all 
radiologists are shown in Table 1.
Test-set
The Breast Screen Digital Imaging Library of New South Wales 
was the source of all images and all recorded data were deiden-
tified. Each case comprised of craniocaudal and mediolaterial 
views of the left and right breasts.
The test set included 60 digital mammograms with 20 cancer and 
40 normal cases. The images were randomly ordered within the 
test-set and all participant were exposed with this same order. 
All 20 cancer cases were biopsy-proven, whilst the normal cases 
were interpreted as being cancer-free by two screen readers and 
then had a normal follow-up screening mammograms 2 years 
later with no interval cancer. Normal images were reported by 
these readers as being completely normal or containing benign 
appearances such as oil cysts, intramammary lymph nodes and 
calcified fibroadenomas. The cancer cases were consisted of 
four discrete masses, two calcifications, five non-specific densi-
ties, five stellate lesions and four spiculated masses. The types of 
cases selected were representative of those presenting in a breast 
screening environment.
Test-set reading
All images were read using a pair of five megapixel medical grade 
display monitors that were calibrated to the Digital Imaging and 
Communication in Medicine Gray Scale Display Function.
In line with routine radiology practice, each reader was asked 
to identify and locate lesions suspicious for malignancy or 
lesions that required further assessment, as well as to provide an 
interpretation scores in their decision. They were able to mark 
as many lesions as they could identify on each case using the 
following interpretation scale: 1, normal; 2, benign; 3, equivocal; 
4, suspicious; 5, malignant. If no lesion was marked, the software 
automatically rated the case as being normal. Readers were not 
informed of the number of normal and abnormal cases.
Data analysis
Jackknife free-response receiver operating characteristics 
(JAFROC) figure-of-merit (FOM),18 receiver operating char-
acteristic, area under curve (ROC AUC), case and location 
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sensitivity and specificity were calculated for each individual 
participant. Case sensitivity was defined by the proportion 
of abnormal cases that were correctly identified as being 
abnormal. Location sensitivity was defined as the propor-
tion of abnormal cases where the lesion was correctly marked 
(within 50 pixel of radius from the centre of lesion) and given 
a confidence score of 3 and above. Specificity was defined by 
the proportion of normal cases given a confidence score of 2 
and below.
ROC is a case-based parameter and thus, when a reader did 
not locate the cancer correctly but correctly identified the case 
as abnormal, a correct score is given to that reader. To over-
come this issue, a free-response receiver operating character-
istics curve was also used.19 JAFROC is a lesion-based method 
for analysing free-response data (multiple reader and multiple 
case studies) and is calculated based on number of true lesion 
locations and number of normal cases rated by observers. 
For the observer studies, the JAFROC analysis is useful for 
assessing reader accuracy in locating cancerous lesions and 
has greater statistical power than conventional ROC anal-
ysis, which neglects location information.20 JAFROC, there-
fore, takes into account when some readers correctly identify 
abnormal cases but incorrectly locate the lesion.
The three groups of radiologists were compared using Kruskal–
Wallis test followed by the ranked-based version of Tukey’s 
honest significant difference criterion. MATLAB software 
2017 (Mathwork, Natick, MA, USA) was used to perform this 
statistical test. The individual comparisons were conducted 
between the following groups:
t NS  vs  screening readers with under 5 years’ experience;
t NS  vs  screening readers with over 5 years’ experience;
t Screening readers with under 5 years’ experience  vs  screening 
readers with over 5 years’ experience
Non-parametric analysis using Spearman’s rank order correlation 
was used to explore the association between diagnostic accuracy 
and experience parameters of the readers. SPSS software (v. 22) 
was used for this statistical analysis. A difference with p-value of 
less than 0.05 was considered as significant.
RESULTS
With regards to reader characteristics, a number of statistical 
differences were found between the pairs of reader groups and 
these are shown in Table 2. The NS group was significantly 
younger than each group of the screen readers, whilst no 
differences in age were noted between the screening radiol-
ogists. The number of hours and number of mammogram 
Table 1.  The characteristics of 63 radiologists included in the study
Reader characteristics Categories
Non-screening 
radiologists (n = 11)
Screening radiologists 
with under 5 years’ 
experience (n = 27)
Screening radiologists 
with over 5 years’ 
experience (n = 25)
Readers' age
≤30 3 (27) 0 0
31–39 8 (73) 11 (41) 1 (4)
≥40 0 16 (59) 24 (96)
Number of years since qualification of 
radiologist
≤5 7 (64) 19 (70) 1 (4)
6–10 4 (36) 2 ( 8) 3 (12)
≥11 0 6 (22) 21 (84)
Number of years reading screening 
mammogram
0–5 11 (100) 27 (100) 0
≥6 0 0 25 (100)
Number of cases reading mammograms 
per week
≤20 10 (91) 7 (26) 0
21–50 1 (9) 6 (22) 3 (12)
51–100 0 5 (18) 9 (36)
101–150 0 4 (15) 3 (12)
151–200 0 4 (15) 2 (8)
≥200 0 1 (4) 8 (32)
No of hours reading mammograms per 
week
≤4 11 (100) 12 (45) 6 (24)
5–10 0 6 (22) 13 (52)
11–15 0 2 (7) 3 (12)
16–20 0 4 (15) 1 (4)
21–30 0 1 (4) 1 (4)
≥30 0 2 (7) 1 (4)
Fellowship training in breast imaging
Yes 0 15 (56) 4 (14)
No 11 (100) 12 (44) 21 (84)
Numbers in parenthesis for reader characteristics are the percentage values.
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cases read per week was also significantly lower for the NS 
radiologists than it was for each of screening radiologists 
groups. Correlation analysis, which examined the relationship 
between the accuracy of all three groups of readers and their 
reader characteristics, demonstrated no statistically signifi-
cant associations.
Case sensitivity, specificity, lesion sensitivity, ROC (AUC) 
and JAFROC (FOM) were calculated for all three groups 
and summarized in Table  3. For each of performance vari-
ables, Table 3 lists the observed means, the variable SDs and 
the lower and upper bounds for the calculated confidence 
intervals (CIs). The CIs were calculated using t-distribution, 
sample SD as an estimate for the population SD, σ and confi-
dence level c = 0.95. The calculated mean scores for all perfor-
mance metrics of the NS radiologists were lower than each 
of the screening groups of radiologists (Table 3). The lowest 
performance score for the NS radiologists were location sensi-
tivity [m = 0.26; SD = 0.16; 95% CI (0.16–0.37)] whilst the 
highest value was specificity [m = 0.75; SD = 0.14; 95% CI 
(0.7–0.81)].
Kruskal–Wallis test showed that there were significant differences 
in sensitivity (p < 0.001), location sensitivity (p < 0.001), ROC 
AUC (p < 0.001) and JAFROC FOM (p < 0.001) between the three 
groups of radiologists, whilst no significant difference was found in 
specificity (p = 0.08). When comparisons in accuracy were carried 
out between the NS radiologists and the less experienced screening 
radiologists, the scores for the NS radiologists were significantly 
lower in terms of case sensitivity (p < 0.001), location sensitivity 
(p < 0.001), ROC AUC (p < 0.01) and JAFROC FOM (p < 0.001), 
but not for specificity (p = 0.84). The NS group also demonstrated 
significantly lower accuracy in case sensitivity (p < 0.001), location 
sensitivity (p < 0.001), ROC AUC (p < 0.001) and JAFROC FOM (p 
< 0.001) compared with more experienced screening radiologists 
but no difference found in specificity (p = 0.96). When two groups 
of screening radiologists were compared there were no differences 
in any measured values.
Table 2. Pairwise comparison of reader characteristics for the three groups
Reader characteristics
Non-screening 
radiologists
Screening radiologists
(<5 years’ experience)
Screening radiologists
(>5 years’ experience) p-value
Reader’s age
32.0 (29, 35) 43.0 (37, 55) 56.0 (43, 67)
b<0.001a
c<0.001a
d0.02a
Number of years since qualification as a radiologist
4.0 (1.0, 8.0) 4.0 (1.0, 8.0) 20 (11.5, 22.5)
b0.66
c0.001a
d0.001a
Number of years reading screening mammogram
0.0 (0, 3.0) 1.0 (0, 4.0) 16.0 (10, 22)
b0.23
c<0.001a
d0.001a
Number of cases read per week
1.0a (1.0, 1.0) 3.0b (1.0, 4.0) 2.0c (2.0, 3.0)
b<0.001a
c<0.001a
d0.04a
Number of hours reading per week
1.0d (1.0,1.0) 2.0e (1.0,4.0) 2.0e (1.5,2.5)
b0.003a
c<0.001a
d0.66
aa statistically significant difference; (a), Indicates less than 20 cases; (b), Indicates 51–100 cases; (c), Indicates 21–50 cases; (d), Indicates 
less than 4 hrs; (e) Indicates 5–10 hrs.
bDifference between non-screen and screen readers with under 5 years’ experience.
cDifference between non-screen and screen readers with over 5 years’ experience.
dDifference between screen readers with under and over 5 years’ experience.
Table 3.  Mean performance metrics for the three groups of radiologists
Diagnostic 
accuracy
Non-screening radiologists
Screening radiologists
(<5 years’ experience )
Screening radiologists
(>5 years’ experience )
Mean (SD) 95% CI Mean (SD) 95% CI Mean (SD) 95% CI
Sensitivity 0.54 (0.2) 0.4–0.66 0.84 (0.1) 0.8–0.88 0.83 (0.15) 0.76–0.89
Specificity 0.75 (0.14) 0.7–0.81 0.76 (0.21) 0.68–0.84 0.81 (0.14) 0.75–0.87
Lesion sensitivity 0.26 (0.16) 0.16–0.37 0.76 (0.14) 0.7–0.81 0.75 (0.15) 0.68–0.81
ROC AUC 0.73 (0.1) 0.66–0.8 0.84 (0.97) 0.8–0.88 0.86 (0.73) 0.83–0.89
JAFROC FOM 0.44 (0.07) 0.4–0.49 0.78 (0.11) 0.73–0.82 0.79 (0.09) 0.75–0.83
CI, confidence interval; JAFROC (FOM), Jack-knife free-response receiver operating characteristics (figure-of-merit); ROC (AUC), receiver 
operating characteristics (area under curve); SD, standard deviation.
Numbers in parenthesis are the standard deviation (SD).
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DISCUSSION
The process of image reporting is a vital component of patient 
management and it depends largely on individual radiologist’s 
accuracy. The study has compared screening and NS radiolo-
gists in screening mammogram interpretation and indicates that 
radiologists from a NS country have lower sensitivity and accu-
racy than screening radiologists. It has not addressed the impact 
of training NS radiologists on performance. We found that the 
NS radiologists had lesion sensitivity and JAFROC FOM scores 
that were two and four times lower, respectively, than the less 
experienced group of screening radiologists. With a case sensi-
tivity of 54% for the NS readers, it is not merely the localization 
of the abnormality that was a challenge, but also the ability to 
recognize an abnormal image.
JAFROC FOM presents the probability that a lesion will be given a 
higher rating score compared with a no-containing lesion location 
on a normal image. This requires a different understanding of the 
resultant AUC values as unlike a 0.5 value representing a random 
score for a normal ROC analysis, this is no longer the case with 
JAFROC. JAFROC does, however, take into account location infor-
mation which is a powerful indicator of radiologists’ accuracy and 
is, therefore, a valid and effective measure for assessing diagnostic 
accuracy of radiologists. In our cases, the JAFROC (0.44) scores for 
the NS radiologists is impacted by their number of normal images 
identified correctly, since the specificity was high (75%) whilst the 
lesion sensitivity was low (26%).
To understand this low performance better, it is worthwhile 
going back to the eye tracking studies,12,21 which explained how 
experts in radiology use an initial holistic review to identify areas 
of abnormality, followed by visual fixation on the abnormality in 
question. However, the fact that case sensitivity and lesion sensi-
tivity for the NS radiologists was low may suggest that initial 
visual detection may be at least part of the reason why these 
readers missed so many cancers. Such detection relies on having 
a firm understanding of what constitutes a normal image, so that 
any abnormal features trigger a rapid response. This requires 
effective initial training coupled with substantial and ongoing 
experience. However, in Mongolia, it is difficult for radiolo-
gists to establish adequate practice and skills in mammographic 
interpretation under the current 2-year program in radiology 
residency, which does not include subspecialty training in 
breast imaging. In addition, workload in mammography units 
in Mongolia is relatively low because of the lack of a national 
screening program.
The ability to recognize normal images is also an important 
measure of accuracy and previous work9 has shown that when 
sensitivity is the same, specificity can be a powerful discrim-
inator between expert and less-experienced observers. Inter-
estingly, no significant differences were found for specificity 
between any of our groups of readers. Due to the low prevalence 
of breast cancer,22 the NS radiologists may have a higher deci-
sion threshold when declaring the presence of a cancer, thus 
potentially explaining both the specificity (the large majority 
of cases are not expected to have cancer) and sensitivity results 
(abnormal cases have to be obvious to be declared as abnormal). 
This hypothesis is supported by number of studies,23–26 which 
suggest that infrequent targets are often missed, which may 
explain the overall accuracy of the NS radiologists. This prev-
alence effect may be ameliorated by exposure to an increasing 
number of abnormal images,23 suggesting that tailored educa-
tional programs with a range of cancer types may be necessary, 
since clinical experience may not meet the demands for adequate 
practice in mammographic examination in Mongolia.
The underlying differences in reader characteristics may explain 
in part the observed findings on diagnostic accuracy. There was, 
e.g. no evidence of fellowship training amongst the NS radiol-
ogists, in contrast to the approximately 45 and 16% of less and 
more experienced screening radiologists, who had completed 
such a program. In addition, higher number of readings per year 
have been shown to be critically linked to better accuracy,9,15,27 
but achieving such experience through clinical practice is unreal-
istic in Mongolia due to lack of a screening program. We did not 
find any significant relationships for any of the groups between 
the reader parameters and measures of diagnostic accuracy, 
although it has been showed in prior studies that radiologists’ 
experience, practice volume9,15,28 and attendance of specialized 
training13,29 are associated with better accuracy. The absence of 
this finding may be the result of limited power30 due to small 
number of individuals per category, as opposed to representing 
an acceptance of the null hypothesis.
It should be acknowledged that the test-set originated from Austra-
lian females undergoing screening mammography, and therefore, 
the diagnostic accuracy of the NS radiologists may in part result 
from the lack of experience dealing with images from such a cohort 
of females. Ethnically-dependent variations of breast morphology 
and density could have contributed to our findings. In addition, 
this study did not involve NS readers who have more than 5 years’ 
experience in mammographic interpretation; however, this reflects 
the very limited number of experienced breast radiologists in the 
country. We should finally acknowledge possible screening group 
familiarity with BREAST test-sets which may have enhanced diag-
nostic accuracy.
In summary, mammographic performance of the radiologists in a 
country which does not employ screening is less good at detecting 
breast cancer in a test-set than radiologists from Australia. The 
absence of screening program and the associated educational and 
quality activities is most like a major contributing factor.
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4.2 Bridging section for chapter four 
 
Diagnosing breast cancer at its early stage is critical, because effective treatment 
can be available to stop its progression. As one of the most important decision 
makers within multidisciplinary team, the radiologists’ interpretation plays a vital role 
in diagnostic pathways. With mammographic screening programs (as well as 
advances in treatment), the numbers of deaths from breast cancer have been 
reported to be reduced by up to 40% [1, 2]. However, not all women benefit from 
mammography due to its reduced ability detecting abnormalities for young women 
with dense breasts. It is not surprising then a sizable proportion (30%) of breast 
malignancies are missed (false negatives) during screening examinations [3, 4]. 
Also, false positives occur commonly, causing unnecessary diagnostic workouts, 
which are costly on several fronts. In consideration of their multifactorial nature, 
some errors are reviewed as inevitable [5]. However, understanding potential 
sources of error will enable the development of evidence-based solutions toward 
decreasing misdiagnoses, which further help to improve patient outcomes.  
 
Although not well-understood, some of the reasons why radiologists fail to diagnose 
malignancies have been recognised such as characteristics related to the lesion 
(radiographically subtle – lesion that is difficult to be detected) [6, 7] and patient (high 
density – BI-RADS category C and D densities) [8, 9] as well as technical factors 
(positioning and compression) [10]. However, most of the missed cancers are visible 
when retrospectively reviewed and therefore must undetected or unrecognised, 
highlighting the importance of better understand reader performance [11, 12]. To 
date, the majority of current observer investigations have been conducted among 
 
 
62 
Western countries, where mammographic screening is well established and well 
maintained with rigorous quality assurance programs. In such countries, quality of 
radiology education appears to be favourable compared with less developed 
countries such as Mongolia. Even with such supportive settings, radiologists’ miss 
rates in the West are still high. Unlike Western countries, such supportive system are 
less available in developing countries such as Mongolia, suggesting high rates of 
misdiagnoses among radiologists based in less developed nations, where advanced 
disease presentation occurs frequently and support structures are less available. 
Nonetheless, little is known about mammographic performance of radiologists 
among less developed countries including Mongolia. 
 
In order to accurately measure the level of performance for Mongolian radiologists in 
reading mammograms, we first used a high difficulty (HD) image-set, because this 
was a standard test-set in Australia to measure and monitor mammographic 
performance of radiologists. However, since results of Mongolian radiologists were 
far lower than those observed among Australian radiologists and considering the 
lack of screening practice in Mongolia, image difficulty was then reduced in the 
second study. This was called the typical screening (TS) test-set, since it 
represented better typical mammographic screening case difficulty. It should be 
noted that inclustion of the local images could have potential to change the 
performance of Mongolian radiologists. However as mentioned in the previous 
chapter, collection of early cancer images from Mongolia remains very difficult.  
 
In the previous study (Chapter 3), mammographic performance for Mongolian 
radiologists was examined using HD mammograms and was demonstrated to be 
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relatively lower than that noted for Australian readers. In particular, case and location 
sensitivities at 54% and 26% respectively were lower than that of not only 
Australians but also readers from other countries [13, 14]. With limited experience in 
screening practice, Mongolian readers may have faced challenges in reading high 
difficulty mammograms (since images from BREAST program were used in the 
previous study), since the country does not have a formal screening program. By 
acknowledging the absence of a screening program in Mongolia, the next piece of 
the work was conducted with TS images, which can be less difficult than the 
previously reported images.  The reading scores were then compared between these 
difficult and typical image-sets to better understand the actual level of performance 
existing in Mongolia. As used in the previous study, validated design and methods of 
assessing reader performance were used [15].  
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Observer Variability in Breast Cancer
Diagnosis between Countries with
and without Breast Screening
Delgermaa Demchig, MD, Claudia Mello-Thoms, PhD, Warwick Lee, MD, PhD,
Khulan Khurelsukh, MD, Asai Ramish, MD, PhD, Patrick Brennan, PhD
Rational and Objectives: Image reporting is a vital component of patient management depending on individual radiologists’ perfor-
mance. Our objective was to explore mammographic diagnostic efficacy in a country where breast cancer screening does not exist.
Materials and Methods: Two mammographic test sets were used: a typical screening (TS) and high-difficulty (HD) test set. Nonscreening
(NS) radiologists (n = 11) read both test sets, while 52 and 49 screening radiologists read the TS and HD test sets, respectively. The
screening radiologists were classified into two groups: a less experienced (LE) group with ≤5 years’ experience and a more experi-
enced (ME) group with ≥5 years’ experience.
A Kruskal–Wallis and Tukey–Kramer post hoc test were used to compare reading performance among reader groups, and the Wilcoxon
matched pairs tests was used to compare TS and ND test sets for the NS radiologists.
Results: Across the three reader groups, there were significant differences in case sensitivity (χ2 [2] = 9.4, P = .008), specificity (χ2 [2] = 10.3,
P = .006), location sensitivity (χ2 [2] = 19.8, P < .001), receiver operating characteristics, area under the curve (χ2 [2] = 19.7, P < .001)
and jack-knife free-response receiver operating characteristics (JAFROCs) (χ2 [2] = 18.1, P < .001).
NS performance for all measured scores was significantly lower than those for the ME readers (P < .006), while only location sen-
sitivity was lower (χ2 [2] = 17.5, P = .026) for the NS compared to the LE group. No other significant differences were observed.
Conclusion: Large variations in mammographic performance exist between radiologists from screening and nonscreening countries.
Key Words: Breast cancer; mammographic screening; reader performance; observer variability; developing country.
© 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
INTRODUCTION
T he incidence of early diagnoses of breast cancer remainslow in developing countries (1) due to differences indisease profile, health-care systems, and socioeconom-
ic conditions compared to wealthier countries. For example,
more than half of breast cancers in developed countries are
detected at stage I, while this figure appears to be approxi-
mately 20% among developing nations, where population
screening is often not available (2,3). It is well reported that
more advanced breast cancers lead to worse outcomes (4);
however, this unfavorable prognosis can be effectively miti-
gated through early detection. It is therefore important for
nonscreening (NS) countries (countries with no official breast
cancer screening program) to establish functional and effec-
tive strategies to increase early diagnosis of breast cancer.
Mammographic screening (MS) has been confirmed as an
effective approach to detecting most breast cancers at a pre-
clinical stage and therefore results in mortality reduction (5–7).
However, the level of MS implementation among NS coun-
tries varies largely (8,9), resulting from limited economic
resources, inadequate health infrastructure, and low inci-
dence settings. While an alternative screening method such
as clinical breast examination (CBE) has thus been proposed
(10), there is insufficient evidence to support CBE as a screen-
ing tool (11,12). Indeed, CBE detects cancers when they
become palpable, and therefore, treatment and survival outcome
is less likely to be favorable than those captured by MS (13).
Undoubtedly, MS will be the future of breast cancer pre-
vention among NS countries.
Diagnostic accuracy is critically important in enabling the
early detection of breast cancer; however, the level of accu-
racy remains unknown among NS countries. Interpreting
radiologists play an important role in early diagnoses, but un-
fortunately, errors that have the potential to impact upon
subsequent patient management can occur. For example, in
developed countries, 30% of all types of radiological exami-
nations and 3%–30% of screening mammograms have not been
reported accurately (14,15) due to system and technical factors
Acad Radiol 2018; ■:■■–■■
From the Medical Image Perception and Optimization Group (MIOPeG), Medical
Radiation Science, Faculty of Health Science, The University of Sydney, PO
Box 170, Lidcombe, NSW 2141, Australia (D.D., C.M.-T., W.L., P.B.); Department
of Diagnostic Radiology, The Intermed Hospital (K.K.); Department of Diagnostic
Radiology, National Cancer Center of Mongolia, Ulaanbaatar, Mongolia (A.R.).
Received January 16, 2018; revised February 20, 2018; accepted March 1,
2018. Address correspondence to: D.D. e-mail: delgermaa.demchig
@sydney.edu.au
© 2018 The Association of University Radiologists. Published by Elsevier Inc.
All rights reserved.
https://doi.org/10.1016/j.acra.2018.03.003
1
ARTICLE IN PRESS
but also reader-based errors (16,17). In developing coun-
tries, we have little idea of the extent of radiological error
in mammography.
In a previous study by our group (18) focusing on high-
difficulty (HD) mammograms, where cancers were missed by
at least one of the two radiologists in Australia (in Australian
there is a dual-reader strategy for screening), we found that
the performance of NS radiologists was substantially lower than
both high- and low-experience radiologists based in a country
with MS. This is not surprising because there are large dif-
ferences in health systems, radiology practices, and training
between the two countries. Nonetheless, differences seen
between the NS and screening populations cannot be gen-
eralized to routine mammographic readings because difficult
mammograms were employed in the previous study (18). To
better understand the actual differences between the two reader
populations, it is necessary to use mammograms that repre-
sent routine radiological reporting. Once a more realistic
appraisal of differences between the two groups of radiolo-
gists is available, the type and extent of solutions required to
standardize diagnostic efficacy can be explored.
This study therefore aims to explore the level of mammo-
graphic diagnostic efficacy in an NS country where breast
cancer screening does not exist. As a baseline comparison, the
performance of radiologists from a screening country, Aus-
tralia, where screening exists, will also be recorded.
MATERIALS AND METHODS
The institutional review board approved this study (2016/406).
All 112 participating radiologists gave informed consent.
Test Sets
All screening-based mammograms were sourced from the Breast
Screen Imaging Library of New South Wales (NSW), and
all recorded data were de-identified. The cases were se-
lected by a senior radiologist who works for BreastScreen NSW
and has more than 20 years’ breast screen reading experi-
ence. No diagnostic cases were included in the test sets, and
each case comprised craniocaudal and mediolateral projec-
tions of both breasts.
During the study period, two reading sessions were con-
ducted, each separated by a 1-year interval, with each reading
session using a unique mammographic test set. In total, each
test set had 60 mammographic cases including 20 abnormal
and 40 normal images. All images containing cancer were biopsy
proven, while normal cases were verified by two radiolo-
gists who reported independently that these were normal, or
they were confirmed to be normal after further diagnostic tests.
Normal images were reported by these readers as being com-
pletely normal or containing benign appearances such as oil
cysts, intramammary lymph nodes, and calcified fibroadenoma.
The two test sets had different levels of difficulty. The first
was called the typical screening (TS) test set, and the second
was called the HD test set. The TS test set, which was the
main focus of this work, was created with the aim of repre-
senting images that would present within a TS environment
in Australia. The HD test set is typically used in test-set reader
assessment strategies such as BreastScreen Reader Assess-
ment Strategy (BREAST) (19) and was used in our previous
study (18).
TS Test Set
The aim of this test set was to create an image grouping that
would be typical of a screening environment, where at least
80% of sensitivity was achieved (19). We initially used 180
mammographic cases including 60 cancers from the Breast
Screen Imaging Library of NSW that had been used by the
BREAST platform and read by 311 radiologists. First, the
total number of readers who correctly identified each cancer
case was calculated, and those cases correctly identified by
more than 80% of the readers were selected, which resulted
in 24 cases. These 24 cases were then examined by three
breast radiologists, two with more than 20 years and one
with 3 years of screen reading experience. Of these cancer
cases, 20 were chosen to represent a typical level of difficul-
ty within a screening environment. The cancer lesions were
five stellate lesions, three architectural distortions, three
stellate/architectural distortions, two nonspecific densities, two
discrete masses/calcifications, three speculated masses, and two
calcifications. Normal cases (n = 40) in this test set were ran-
domly selected and validated as described above.
HD Test Set
This set of images was one of the standard test sets that were
designed for assessing and monitoring BreastScreen readers in
Australia using the BREAST platform (19). Difficult refers to
the fact that all cases containing cancers were missed by at
least one radiologist at the time of screening (in Australia, two
independent radiologists read all screening images) (20). Normal
images in this test set were selected randomly from the NSW
screening database.
Study Participants
Two observer groups were involved in this work, one from
a developing country (the NS country) where mammo-
graphic breast screening does not occur and the other from
a developed country (Australia) where biennial MS occurs.
It should be acknowledged that medical training for these
two countries differ greatly. For example, in the NS country,
radiologists have to be a graduate of a 6-year medical uni-
versity with a subsequent 2-year radiology residency training.
This is in contrast to Australia, where, to become a radiol-
ogist, one must complete 4–60 years of medical school with
a subsequent 5-year postgraduate radiology education. In ad-
dition, in Australia, radiology graduates need to have completed
an additional subspecialty training in breast imaging to become
a breast radiologist, whereas this is not required in the NS.
Details on demographic (age and gender), experience
(number of years since radiology qualification; number of years
interpreting mammography), and practice (number of hours
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and number of cases read per week) were obtained using a
questionnaire. The participating readers were also asked whether
they had been involved in fellowship training in breast imaging
consisting of more than 3 months. The characteristics of par-
ticipating radiologists are shown in Table 1.
THE NS GROUP
A total of 11 radiologists from an NS country were re-
cruited and read both test sets independently during BREAST
(19) workshops at the first internationally accredited hospi-
tal in the country located in the capital city. These readers
were collectively called the NS group because they did not
interpret screening mammograms (breast screening does not
exist currently in the country). They were affiliated to three
medical centers and represented approximately 80% of the total
number of breast readers involved in mammographic inter-
pretation nationwide. They had a range of 1–5 years of
experience in a diagnostic setting.
THE SCREENING GROUP
In total, 101 readers were involved in the study from a de-
veloped country where breast screening was performed, and
52 and 49 radiologists read the TS and HD test sets, respec-
tively. These reading sessions were conducted at BREAST
(19) workshops held during the Royal Australian New Zealand
College of Radiologists’ scientific meetings between 2013 and
2017. With a frequent interpretation of screening mammo-
grams as part of clinical practices, these readers were denoted
as the screening group. To match the duration of mammo-
graphic interpretation experience with the NS group, screening
readers were further subdivided into a less experienced (LE)
group with up to 5 years of experience and a more experi-
enced (ME) group with more than 5 years of experience
(Table 1).
Test Set Reading
All readings were performed on a pair of five-megapixel
medical-grade display monitors that were calibrated using the
Digital Imaging and Communication in Medicine Gray Scale
Display Function. Of 11 readers, 3 radiologists mostly inter-
pret mammograms using film technology while the rest
regularly read full field digital images. The 60 cases were dis-
played in the same randomized order, and cancer prevalence
was unknown for each radiologist, but participants were told
that test sets were cancer enriched. A detailed instruction was
displayed on the screen at the start of each reading and ex-
plained verbally before the experiment began. Postprocessing
tools such as zooming and panning were available to each ob-
server, and a time limit was not imposed while reading the
test sets. The observers were unable to access prior images.
The observers were able to access the online BREAST plat-
form (19) to record their decisions. They were asked to mark
the location of as many lesions as they could identify on each
projection and score each location using the following con-
fidence scale: 2 = benign, 3 = equivocal, 4 = suspicious,
5 = malignant. If no lesion was marked, the software auto-
matically rated the case as being normal and gave a score of
1. In radiology, while the Breast Imaging Reporting and Data
System is used in the United States, this system is not appli-
cable in the Australian setting, where a different standardized
reporting system is being used. Therefore, because the base-
line group were Australians, the current study follows the
Australian standard in reporting mammograms.
The Performance Metrics
Performance was assessed using the following metrics: case
sensitivity, specificity, location sensitivity, receiver operating
characteristics (ROCs), area under the curve (AUC), and jack-
knife free-response receiver operating characteristics
(JAFROCs), figure of merit (FOM). Case sensitivity was
defined by the proportion of correctly identified abnormal
cases given a confidence score of 3 and more, while speci-
ficity was defined by the fraction of correctly identified normal
cases given a score of 2 and below. Location sensitivity was
defined by the proportion of abnormal cases where location
was correctly marked within a 50-pixel radius from the center
of the lesion and given a score of 3 and higher.
TABLE 1. Characteristics of All Radiologists Included in the
Study
Reader Parameters
NS Group
(n = 11)
LE
Screening
Group
(n = 46)
ME
Screening
Group
(n = 55)
Age 32 (6) 41 (9) 51 (17)
Number of years reading
mammograms
0 (3) 2 (5) 15 (10)
Number of hours reading
mammograms per week
≤4 10 [91] 23 [50] 17 [31]
5–15 1 [9] 12 [26] 32 [58]
≥16 0 11 [24] 6 [11]
Number of cases reading
mammograms per week
≤20 9 [82] 21 [46] 13 [24]
21–100 2 [18] 14 [30] 23 [42]
≥101 0 11 [24] 19 [34]
Fellowship training of
more than 3 months
Yes 0 22 [48] 39 [71]
No 11 [100] 24 [52] 16 [29]
Note: Numbers in rounded parentheses represent interquartile range,
while those in square parentheses indicate percentage values.
LE, less experienced screening radiologists; ME, more experi-
enced screening radiologists.
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Data Analyses
Three groups of radiologists were compared using the Kruskal–
Wallis test followed by multiple comparisons using the Tukey–
Kramer post hoc test. The individual comparisons are shown
below:
• NS group vs LE screening group
• NS group vs ME screening group
• LE screening group vs ME screening group.
In addition, because the same NS radiologists read both test
sets, the performance of the NS readers were compared between
TS and HD test sets using the Wilcoxon matched pairs test
to specifically examine if reading a TS test set improved per-
formance levels compared to the previously reported
performance values for the HD test set.
In order to explore any association between performance
scores and the experiences of each of the three radiologist
groups, a nonparametric Spearman test was conducted. The
SPSS software (version 22) (IBM, Armonk, NY) was used
for all statistical analyses. A difference with a P value of equal
to or less than .05 was considered a significant finding.
RESULTS
Case sensitivity, specificity, location sensitivity, ROC AUC,
and JAFROC FOM were calculated for all three groups of
radiologists and are summarized in Figure 1. Across the three
groups, there were significant differences in case sensitivity
(χ2 [2] = 9.4, P = .008), specificity (χ2 [2] = 10.3, P = .006),
location sensitivity (χ2 [2] = 19.8, P < .001), ROC AUC (χ2
[2] = 19.7, P < .001), and JAFROC (χ2 [2] = 18.1, P < .001).
The comparison between the NS and LE groups demon-
strated that only location sensitivity (χ2 [2] = 17.5, P = .026)
was significantly different while the NS performance in all
measured values were significantly lower than those for the
ME readers (P values are summarized in Table 2). When the
two groups of screening readers were compared, only the ROC
(AUC) score for the LE group was significantly lower than
that for the ME group (Table 2).
The false-positive (FP) rates were also significantly differ-
ent (χ2 [2] = 9.6, P = .008) across the three groups with the
highest rate for the NS readers (27.0 ± 13.2), followed by the
LE (25.5 ± 27.8) and ME groups (13.2 ± 20.9). When the
pairwise comparison was carried out, the FP rate for NS readers
were significantly higher (χ2 [2] = 2.9, P = .009) than that for
the ME group but nonsignificant with the rate for the LE
group.
In addition, the case sensitivity by the lesion types was also
calculated for all three groups and demonstrated in Table 3.
Significant differences in speculated mass (χ2 [2] = 8.6, P = .01)
and stellate lesions (χ2 [2] = 12.0, P = .002) were noted across
the three groups. The NS performances in speculated mass
(39.3 ± 29.0, P = .01) and stellate lesion (61.0 ± 20.3, P = .002)
were significantly lower than that for the ME group but non-
significant when compared with the LE performance (Table 3).
When the performance of the NS group was compared
between the HD and TS test sets, no significant changes were
observed in any of the measured scores (Table 4).
No associations were found between reader characteris-
tics and performance metrics in any of the three groups of
radiologists.
DISCUSSION
Reduced diagnostic accuracy can result in delayed diagno-
ses. This study aimed to identify possible differences in screening
0 0.2 0.4 0.6 0.8 1
Case sensitivity
Specificity
Location sensitivity
ROC AUC
JAFROC FOM
ME group
LE group
NS group
Figure 1. The median performances for
each of the three groups of radiologists
when reading a typical screening test set.
TABLE 2. Pairwise Differences between Reader Cohorts
across the Three Groups;. the Numbers Represent P Values
Performance
Metrics
NS vs LE
Screening
Readers
NS vs ME
Screening
Readers
LE vs ME
Screening
Readers
Case sensitivity .153 .006* .646
Specificity .429 .006* .185
Location sensitivity .026* <.001* .14
ROC (AUC) .132 <.001* .029*
JAFROC (FOM) .077 <.001* .088
* Statistically significant P value.
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performance between the NS readers from a developing country
and the screening readers from a developed country using a
TS test set. The previous study with an HD test set had in-
dicated that the performance of the NS readers was relatively
lower than both expert and nonexpert groups of readers, and
therefore, this study aimed to identify possible changes in the
performance of the NS radiologists between the HD and TS
image sets. The data demonstrated that even with a more typical
test set, performance measures arising from the NS group were
significantly lower than those for the ME screening group,
while location sensitivity was lower than that of the LE screen-
ing group. Importantly, NS performance was not shown to
be improved with the TS test set compared with the HD test
set, reinforcing the conclusion of the previous study that a
low level of performance exists for these NS radiologists.
The persistently low level of performance of the NS ra-
diologists with those that screen read regularly can be explained
to some extent by expertise level. When expert readers in-
terpret an image, a holistic response initiates and directs an
ensuing visual fixation of potential abnormalities (21). However,
with the NS radiologists, 63% and 34% in case and location
sensitivities, respectively, averaged across both test sets would
suggest that this expert sequence of events is not occurring.
Specifically, the ability to extract sufficient information from
an initial global impression requires having a firm under-
standing of normal imaging finding so that abnormal features
trigger a useful response. This type of expertise requires sub-
stantial experience that can only be established through
minimum annual readings facilitated by an active screening
program (22,23). While effective training and ongoing clin-
ical practice can develop these skills, in the country where
the NS radiologists were recruited, it is difficult to achieve
proper knowledge and skills under the current 2-year radi-
ology residency program, which does not include a subspecialty
training in breast imaging. This is in contrast to the 5 years
of training program in many other countries (24,25), where
better performance of readers has been reported (26).
Another important finding of our study was the FP rates
for NS readers, which were significantly higher (27%) than
that for the ME screening group (13%), when reading the TS
test set. This finding is not surprising because Australia employs
a well-established screening protocol with double reading,
which can potentially influence the numbers of FPs, whereas
this does not happen in the NS country. It should also be
acknowledged that there are no practice guidelines on recall
rates in the NS country, and therefore, the NS reader may
feel less restricted about recalling patients unnecessarily com-
pared to elsewhere.
In terms of lesion types that were missed, the NS readers
also demonstrated lower sensitivity in detecting all types of
lesions in the TS test set than the two groups of screening
readers. Specifically, their performance in detecting specu-
lated mass (39%) and stellate lesions (61%) were significantly
lower than that for the ME group. It is important to note
that the lesions included in the test set were selected from
small and subtle findings, and in the NS country, the expec-
tations in reporting mammograms are different from those in
Australia. For example, in the NS country, a small number
of patients is expected to have cancer, and therefore, radi-
ologists have a tendency not to recall women with a small
lesion but rather to put them on the list of regular monitor-
ing. Therefore, early cancer findings such as stellate and small
speculated mass lesions may not be familiar and interpre-
table among radiologists from the NS country, highlighting
the need for dedicated training to encourage best practice.
The underperformance of the NS radiologists may also be
linked to other factors. These individuals may have a high
TABLE 3. Case Sensitivity by Lesion Type in the TS Test Set among Three Groups
Lesion Types
NS Group
(n = 11)
LE Screening Group
(n = 19)
ME Screening Group
(n = 30) P value
Architectural distortion/stellate 84.8 (17.4) 84.2 (23.2) 90.0 (17.4) .372
Nonspecific density 72.7 (41.0) 81.5 (29.8) 86.6 (22.5) .661
Architectural distortion 66.6 (29.8) 77.1 (29.5) 83.3 (22.7) .201
Stellate lesion 61.0 (20.3) 74.4 (26.0) 88.0 (12.5) .002*
Discrete mass/calcifications 59.0 (43.7) 68.4 (41.5) 73.3 (28.4) .687
Calcifications 59.0 (37.5) 73.8 (33.9) 71.6 (34.0) .491
Speculated mass 39.3 (29.0) 64.8 (36.0) 73.3 (28.2) .013*
Numbers in parenthesis are standard deviations.
* Statistically significant P values (NS vs ME groups).
LE, less experienced; ME, more experienced; NS, nonscreening.
TABLE 4. The Performance Metrics of the NS Group in TS
and HD Test Sets
Performance Metrics TS Median (IQR) HD Median (IQR)
Case sensitivity 0.7 (0.12) 0.57 (0.07)
Specificity 0.73 (0.14) 0.83 (0.1)
Location sensitivity 0.38 (0.21) 0.31 (0.3)
ROC (AUC) 0.72 (0.13) 0.77 (0.06)
JAFROC (FOM) 0.48 (0.14) 0.46 (0.07)
Note: None of the comparisons were statistically significant.
IQR, interquartile range; JAFROC (FOM), Jack-knife Free-response
receiver operating characteristics, figure of merit; ROC (AUC), re-
ceiver operating characteristics, area under the curve.
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decision threshold when declaring the presence of abnormal-
ity due to the very low prevalence of breast cancer in the
country (27); therefore, cancer cases may have to be quite
obvious to be declared as abnormalities. This would explain
both (low) sensitivity and (high) specificity results, a hypoth-
esis supported by a number of cognitive physiology studies
(28,29) showing the association between a high miss rate and
a low probability of a target being present. However, it is im-
portant to note that this hypothesis may not be supported by
recent radiologist-based studies, including those by our own
group (30,31).
Based on the potential reasons for error, educational ini-
tiatives may be the best solution for improving individual
performance because the low prevalence setting does not en-
courage such skills. For example, a dedicated training program
that includes a high number of abnormal images may ame-
liorate the prevalence impact (32). Even within a relatively
high prevalence setting, it can be difficult to develop reading
skills in screening due to the low absolute number of cancers
that present among the screening population. Therefore,
Australia and UK have provided successful and effective edu-
cational platforms known as the BREAST and PERsonal
perFORmance in mammographic screening to assess and
improve individual performance (32,33). For example, radi-
ologists who regularly read BREAST image sets have
demonstrated improved performance in cancer detection (32),
suggesting that the adoption of this type of activity in NS lo-
cations may help to improve the NS radiologists’ performance.
This study has several limitations. As the focus was on com-
paring the performance of NS radiologists between two test
sets, the study was not designed to enable an understanding
of the possible effect of different image sets or different reader
groups on performance. Also it is possible that due to insuf-
ficient power with our arguably small sample sizes (34), we
were not able to observe any relationship between reader pa-
rameters and performance metrics, although previous workers
(26,35) did demonstrate links between factors such as reader
volume and diagnostic efficacy. Nevertheless, our NS readers
represent 80% of the breast readers nationwide. We should
finally acknowledge that our images were sourced from Aus-
tralia, and therefore, the NS radiologists may lack experience
in dealing with such a specific cohort of women.
In conclusion, these data provide more evidence that there
is a substantial variation in diagnostic performance between
readers from NS and screening countries. This suggests the
need for initiating a strategic solution in these countries in
order to maximize the detection of early breast cancers.
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5.2 Bridging section for chapter five 
 
Mammographic breast density (MD) is a major risk factor for breast cancer. This 
term refers to the appearance in combination of epithelial, stromal and collagen 
components of breast on mammograms. Since its first recognition as a risk factor in 
1976, MD has been extensively investigated and its causative link to breast cancer 
has been reported with varying level up to 6.0 times, when women with highest and 
lowest MD were compared [1-3]. In addition, mammographic sensitivity varies 
between 80-93% for women with low MD and 30-70% for those with high MD [4-6]. 
The importance of MD is twofold. Firstly, as high MD means greater amounts of 
epithelial and stromal tissue elements, where most breast cancers develop, the 
chances of having the disease is greater for women with high MD than low MD 
women [7]. Secondly, it is difficult to examine breast tissue details for women with 
high MD due to lack of contrast between dense and malignant area on 
mammograms. This is called the “masking effect” which contributes to delayed 
diagnoses of breast cancer [8, 9]. Since high MD obscures appearance of cancerous 
tissues on mammograms, incidence of interval cancers (cancers detected following a 
negative screening mammography) is higher among high MD population compared 
with low MD women [10-12]. This effect can also be illustrated with a recent fact that 
81% of ultrasound detected cancers were not seen on mammograms [13].  
 
As MD is an important feature in clinical practice, assessment methods should be 
robust and accurate. To date, varying methods have been used in clinical and 
research settings including qualitative (radiologists’ visual estimation) and 
quantitative (computer software) approaches [14]. However, no such methods are 
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credited as a standard tool for measuring MD, since limitations have been 
consistently reported. For example, a number of computer software have been 
proposed to objectively measure MD based on volume of breast tissue such as 
QuantraTM and VolparaTM, however, their clinical use has not yet been proved and 
therefore, although subjective, breast imaging reporting and data system (BI-RADS) 
remains the most clinically used tool. BI-RADS has 4 grades: A-almost entirely fatty 
and B-scattered fibroglandular densities are combined for low MD, C-
heterogeneously dense, which may obscure detection of small masses and D-
extremely dense which lowers mammographic sensitivity, which together represent 
high MD.  
 
The impact of high MD on radiologists’ performance has been investigated with 
inconsistent results. Whilst most (film-based) literature has shown that high MD 
contributes to reduced accuracy of radiologists [6, 15], some recent studies 
demonstrated alternative findings [16, 17]. For example, Al Mousa et al., 
demonstrated the positive association between high MD and increased cancer 
detection of experienced radiologists [18]. With the increased awareness of the 
association between MD and risk for breast cancer, radiologists demonstrated 
increased attention and scrutiny of high density breasts and therefore cancers were 
located more effectively with the assistance of windowing, levelling and zooming 
functions available with digital technology but not with film-screen based 
technologies [18]. It is generally believed that the sensitivity of mammography 
decreases with increased breast density, high density being not uncommon 
(approximately 50%) among general population, raising the concern of MS 
implementation [19]. Some authors [20] suggest that the first round of screening 
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mammography should allow an evaluation of density status and then those women 
recognised as having high MD (high risk) maybe recommended for alternative 
screening pathways since mammography may have reduced benefit.  
 
In this thesis’s previous two studies, the low performance of Mongolian radiologists 
was documented. Since high MD is a key determinant for mammographic sensitivity, 
it is very important to understand better the distribution of MD amongst Mongolian 
women thus ensuring we provide the best pathways for early detection. Nonetheless, 
information about density remains less clear for women in Mongolia. Therefore in 
this chapter, the distribution of MD was examined in relation to age, body mass index 
and area of residency amongst a reasonably large number of women (n=1985) from 
the National Cancer Centre of Mongolia (NCC). 
 
The first effort to identify MD in Mongolia was conducted by Dr Ramish A., (2009) 
involving 150 health women using Wolfe categories of density. In this unpublished 
study, number of readers, validation of breast density scores and reader experience 
were unclear. More importantly, determinant factors for MD variations including body 
size and socioeconomic status were not considered, which is significant factors 
when investigating MD. To better understand MD among Mongolian women, it is 
therefore essential to characterize MD along with its influential factors, which will 
further help to understand optimum imaging method for breast cancer screening.  
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Introduction
Among women in the world, breast cancer remains 
the most commonly diagnosed cancer. The breast cancer 
incidence (age standardized rate, ASR) was reported in 
Mongolia as 6.0 per 100,000 women in 2013 (Breast 
cancer statistics 2009-2013, NCC, Mongolia). This 
measure, whilst relatively low compared with other 
countries, has been rapidly increasing on an annual basis 
(Troisi et al., 2012) and between 2009 and 2013, the 
number of new cases of breast cancer more than doubled. 
In addition, approximately 90% of breast cancer patients in 
Mongolia are diagnosed at a relatively late stage, resulting 
in a high mortality rate. 
Many risk factors have been reported to be associated 
with breast cancer in the westernized world and these 
include family history, lifestyle activity and hormonal 
factors. However, in recent years, it is increasingly 
recognized that mammographic density (MD) is a 
critically important determinant. Previous authors have 
linked high density with up to 6 times higher risk of 
Abstract
Objective: 0DPPRJUDSKLFGHQVLW\0'LVDVLJQL¿FDQWULVNIDFWRUIRUEUHDVWFDQFHUDQGDQLPSRUWDQWGHWHUPLQDQW
IRUHVWDEOLVKLQJHI¿FLHQF\RIDQ\VFUHHQLQJSURJUDP&XUUHQWO\WKHGLVWULEXWLRQDQGLQÀXHQWLDOIDFWRUVRI0'LVXQNQRZQ
among Mongolian women. This work aims to characterize MD of Mongolian women. Methods: The ethical approval 
was obtained from Research Ethics Board of the University of Sydney (2014/973) and National Ethic Committee from 
Ministry of Mongolia (2015/04). We recruited 1985 women aged 16-83 from the National Cancer Center in Mongolia 
for whom MD and age of each woman was known. From this total group, 983 women also had additional available 
details on height, weight, body mass index (BMI) and area of residency. We investigated the association of each of 
these variables with breast density, which was assessed by using the Breast Imaging Reporting and Data System 
(BIRADS) lexicon. Univariate and multivariate regression analyses were conducted to explore the importance of these 
variables as predictors of MD. Results: Category B (33%) was the most common type of MD, whereas 25%, 18% and 
24% of women belonged to the category A, C and D respectively. The univariate analysis demonstrated that, younger 
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associated with decreased weight (OR=4.5), increased height (OR=0.4) and lower BMI (OR=13.2). Urban women had 
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MD was explained by age (OR=4.5) and BMI (OR=7.3). Conclusion: A high proportion of Mongolian women have 
very high density breasts and age and body size are key factors determining MD among these women. 
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breast cancer resulting in a plethora of research around 
causal factors of, or associations with MD (McCormack 
and Silva, 2006; Boyd et al., 2007). Researchers have 
also linked increased breast density to the aggressiveness 
of tumors particularly for younger women (Bertrand et 
al., 2013). Despite all this increasing evidence around 
density, in Mongolia we know little about MD. It is not 
known for example what is the distribution of density 
within Mongolian women, we have no data associated 
WRULVNIDFWRUVDQGZHGRQRWXQGHUVWDQGWKHLQÀXHQFHRI
age and body size measures. Without this information, it 
LVGLI¿FXOWWRRSWLPL]HSUHYHQWDWLYHVWUDWHJLHVIRUEUHDVW
cancer in Mongolia.
It has also been argued that increased MD can 
hinder the visualization of breast cancer by obscuring 
underlying abnormalities, which contributes to reduction 
in the sensitivity of screening mammography and 
therefore affect optimum imaging protocols (Freer, 
2015). Currently, routine screening mammography is not 
established in Mongolia. The breast screening guidelines 
in Mongolia have to date not included details on modality 
1Medical Image Optimization and Perception Group (MIOPeG) Discipline of Medical Radiation Science, Faculty of Health Science, 
University of Sydney, Sydney, Australia, 2Department of Diagnostic Radiology Intermed Hospital, 3Department of Diagnostic 
Radiology National Cancer Center, Ulaanbaatar, Mongolia. *For Correspondence: Delgermaa.demchig@sydney.edu.au
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choice, instead focusing on breast self-assessment and 
clinical breast examination. These guidelines however are 
of limited value since only one in three women undergo 
breast self-assessment and only 3.2% have experienced 
clinical breast examination as reported in a recent WHO 
review (WHO, 2013). Whilst mammographic screening 
reduces mortality by 15% to 32 % in western countries 
(AIHW, 2014; Pace and Keating, 2014) there is no 
evidence that systems used elsewhere would be effective 
in Mongolia. There is urgency therefore, to identify 
density distributions among Mongolian women so that 
more sophisticated and relevant screening approach are 
employed, facilitating early detection and intervention in 
the disease. 
Breast density can be assessed by various qualitative and 
quantitative methods, involving mostly mammography. To 
date, there is no standard for density assessment however, 
the Breast Imaging-Reporting and Data System (BIRADS) 
is the most common method in clinical practice (Sickles 
et al., 2013), and the only method in Mongolia used to 
report breast density. The objectives of the current study 
are therefore to identify the density distribution among 
Mongolian women using BIRADS density categories to 
establish the relationship between density and women’s 
age and body size and to explore differences in MD 
between urban and rural areas of Mongolia.  
Materials and Methods
The ethical approval was obtained from Research 
Ethics Board of the University of Sydney (2014/973) and 
National Ethic Committee from Ministry of Mongolia 
(2015/04).
Sample size 
This cross-sectional study was based on digital 
mammograms from 1985 women aged 16-83, who 
underwent mostly diagnostic mammography at the 
National Cancer Center (NCC) in Mongolia between 
September 2014 and September 2015. We randomly 
collected all available images for which two standard 
views were accessible. Otherwise, no selection criteria 
were applied for data collection.
From the total group, 983 women also had available 
details on height, weight and body mass index (BMI) 
which were obtained from the hospital registry. The area of 
residency was also recorded for these women and women 
are allocated to the following grouping: Ulaanbaatar-UB 
(urban, capital city) and non-UB (rural) groupings. 
Breast density by Radiologists
The evaluation of breast density was determined by an 
experienced breast radiologist and validated with density 
reading from three breast radiologists who independently 
examined a random sample of 400 of the total number 
of cases. Absolute agreement was used as a measure of 
overall agreement between radiologists and a high inter 
rater reliability was found between the three radiologists. 
Each mammogram was evaluated according to 
BIRADS density categories A-D (Sickles EA et al., 
2013): Category a – almost entirely fatty; Category 
E VFDWWHUHG DUHDV RI ¿EURJODQGXDU  GHQVLW\&DWHJRU\
c- heterogeneously density; Category d- extremely dense. 
Statistical analysis
Logistic regression analysis was used to explore 
univariate and multivariate associations between 
dichotomized MD (categories a and b as low vs c and d 
as high densities) and independent variables age, weight, 
height, BMI and geographical location. Odds ratio (ORs) 
DQGFRQ¿GHQFHLQWHUYDOV&,VZHUHHVWLPDWHG$OO
analyses were performed using SPSS software (version 
22.0). A p value of less that 0.05 was considered as 
VLJQL¿FDQW
Results
The mean age of the 1985 Mongolian women 
examined was 40.55 (±11.8) years with a range of 16-83 
years. Whilst category B (33% of women) was the most 
common type of MD, 25%, 18% and 24% of women 
belonged to the category A, C and D respectively. 
The investigated variables were available for 
983 women and table 1 demonstrates the summary 
characteristics of the study sample on all parameters 
BIRADSa density
Variables Category A Category B Category C Category 
D
Mean ± SD  Mean ± SD Mean ± SD Mean ± SD
Age (years)
     Mean ± SD 52±10.5 41.6±9.0 37.4±8.8 32±7.5
Weight (kg)
     Mean ± SD 71.8±14.2 66.0±10.7 62.3±9.2 56.8±8.4
Height (m)
     Mean ± SD 1.57±0.06 1.59±0.06 1.61±0.07 1.6±0.05
BMI b (kg/m²)
     Mean ± SD 35.9±6.4 31.3±4.9 28.9±4.4 26.3±3.9
Area of residency (N%)
     Urban 197 (82) 289 (90) 146 (92) 250 (94)
     Rural 44 (18) 30 (10) 12 (8) 15 (6)
Table 1. The Baseline Characteristics of the Study 
Population (n=983)
a, BIRADS: Breast Imaging and reporting system, 2013; b, BMI: Body 
mass index
Figure 1. Frequency of Women Allocated to One of the 
Four Breast Density Grouping According to Age Group 
(n=1985).
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groups. The frequency of extremely dense breast (category 
D) was the largest (60%) among the youngest age group, 
consistently declining as age increases and reaching its 
lowest point (2%) among women in the oldest age groups. 
The two oldest age groups contained the highest number 
of women with fatty breasts (Figure 1).
The association between MD and age was explored for 
all 1985 women along with a separate estimation for 983 
women. Since only a small number of women belonged 
to the high density categories among older ages, women 
were then grouped into two groups (below and above 
40 years old) to identify the relationship between age 
and dichotomized MD. Table 2 shows the univariate and 
multivariate associations between MD and all the factors 
examined. Age was shown to be an important predictor 
IRU0'DVLJQL¿FDQWO\LQFUHDVHGULVNRIKDYLQJKLJKHU
dense breasts noted for women aged below 40 years old, 
compared with women aged above 40 years old.
examined. 
Univariate analysis 
Age
The overall age distribution of MD was examined for 
1985 women. Figure 1 demonstrates the age distribution 
RI IRXU FDWHJRULHV RI%,5$'6 DFFRUGLQJ WR ¿YH DJH
Variables Univariate Multivariate
OR 95%CI OR 95%CI
Age (n=1985)
 6.8 (5.5-8.3)*
     >40 1
Age (n=983)
 7.3 (5.4-9.8)* 4.5 (3.4-6.2)*
     >40 1 1
Weight (kg)
 4.5 (3.4-6.0)*
     >64 1
Height (m)
 0.43 (0.3-0.6)*
     >1.6 1
BMI a (kg/m2)
     Normal 13.2 (8.6-20.0)* 7.3 (4.6-11.5)*
     Overweight 5.1 (3.8-7.0)* 3.6 (2.6-5.0)*
     Obese 1 1
Area of residency 
     Urban (UB) 2.2 (1.4-3.5)* 1.5 (0.9-2.5)a
     Rural (non-UB) 1
Table 2. The Association between MD and the Factors
a%RG\PDVVLQGH[Sap, 0.12
Variables Are of residency
Urban Rural 
N (%) N (%)
Age (years)  484 (55) 37 37)
>40 398 (45) 64 (63)
Mean ± SD 40.0 (11.4) 45.0 (12.5)
BMI a (kg/m2) Normal 156 (18) 13 (13)
Overweight 327 (37) 23 (23)
Obese 399 (45) 65 (64)
Mean ± SD 30.3 (6.0) 32.3 (6.0)
Table 3. Age and BMI Distribution by Area of Residency
a , Body mass index
Variables $JH1 Age > 40 (N%) 
Low density High density OR (95% CI) Low density High density OR (95% CI)
Weight (kg)
     >64 95 (60) 63 (40) 1 234 (86) 39 (14) 1
 93 (26) 270 (74) 4.3 137 (73) 51 (27) 2.2
Height (m)
     >1.6 92 (33) 185 (97) 1 127 (75) 43 (25) 1
 96 (40) 148 (60) 0.7 245 (84) 47 (16) 0.5
(0.5, 1.0) (0.3, 0.9)*
BMI a (kg/m2)
     Obese 88 (65) 48 (35) 1 265 (88) 35 (12) 1
     Overweight 64 (30) 147 (70) 4.2 88 (72) 35 (28) 3
(2.6, 6.6)* (1.7, 5.1)*
     Normal 36 (21) 138 (79) 7 16 (47) 18 (53) 8.5
(4.2,11.6)* (3.9, 18.2)*
Area of residency 
     Rural (non-UB) 18 (47) 20 (53) 1 57 (88) 8 (12) 1
     Urban (UB) 170 (35) 313 (65) 0.6 315 (79) 82 (21) 0.5
(0.3,1.2)1 (0.2,1.1)2
a%RG\PDVVLQGH[S1 p, 0.14; 2 p, 0.12
Table 4. Distribution and Association of MD and Investigated Factors
D Demchig et al
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Weight, height and BMI
Body size data were available for 983 women. The 
mean weight was 57.0 kg (±8.4) and 72.0 kg (±14.2) for 
extremely dense and almost fatty categories respectively 
(Table 1). The mean height was 1.59 m (±0.06) and 
was similar across four density groupings. Majority of 
ZRPHQZHUHFODVVL¿HGLQWKHRYHUZHLJKWDQGREHVH
groupings whereas 17% of women grouped in normal 
BMI category. 
Associations were found between MD and body 
size measurements (Table 2). Increased risk of having 
KLJK0'ZDV VLJQL¿FDQWO\ S DVVRFLDWHGZLWK
decreased weight (OR=4.5, 95% CI: 3.4, 6.0), increased 
height (OR=0.43, 95% CI: 0.3, 0.6) and decreased BMI 
(OR=13.2, 95% CI: 8.6, 20.0). 
Area of residency
Table 3 demonstrates the age and BMI distribution 
by area of residency. In total 882 and 101 women were 
allocated to UB and non-UB groupings respectively 
ZLWK8% UHVLGHQWV KDYLQJ VLJQL¿FDQWO\ 25  
&,SKLJKHUGHQVLW\EUHDVWVWKDQQRQ8%
UHVLGHQWV KRZHYHU WKH DVVRFLDWLRQZDVQRW VLJQL¿FDQW
after controlling for age and BMI (Table 2). Since the 
Non-UB women came from across the country, these were 
WKHQIXUWKHUFODVVL¿HGE\JHRJUDSKLFDOORFDWLRQVEXWQR
statistical differences were noted between north vs south 
(p=0.56) nor east vs west (p=0.92) regions of Mongolia.
Distribution and determinant of MD within women of 
different age categories
To identify the differences in determinant factors of 
MD, women over (n=462) and under 40 (n=522) years 
old were compared (Table 4). For the young women, the 
magnitude of odd ratios for some factors were different for 
the two groups of women. This is summarized in table 4. 
Multivariate analysis
Multivariate logistic regression model was built 
to explore the relative importance of the dichotomous 
variables of age, area of residency and BMI as predictors 
of MD, dichotomized into high and low density.  
In the full model, 76% of variation in MD was 
explained by the measured risk factors. After entering 
age, BMI and area of residency into a regression model, 
age (OR=4.5, 95% CI: 3.4-6.2), BMI (OR=7.3, 95% CI: 
ZHUHWKHVLJQL¿FDQWSUHGLFWRUVIRU0'ZKLOVW
area of residency did not contribute to the model (Table 2). 
Discussion
The current study was carried out to explore variations 
of mammographic density (MD) among Mongolian 
ZRPHQXVLQJWKH¿IWKHGLWLRQRI%,5$'6OH[LFRQ7KH
results demonstrated interesting patterns of MD and 
VWDWLVWLFDOO\ VLJQL¿FDQW UHODWLRQVKLSV EHWZHHQ0'DQG
age, body size and area of residency. 
Although density values were almost equally 
distributed between low and high density groupings, 
we expected to observe predominantly low density 
mammographic appearance since the majority of women 
in our study have much greater BMI compared with 
those described by the previous studies (Dai et al., 2014). 
However, a large proportion (24%) of women in our 
VWXG\ZDVFODVVL¿HGDVKDYLQJDQH[WUHPHO\GHQVHSDWWHUQ
(BI-RADS category D) compared with 7.4% and 8.6% in 
USA and China respectively (Dai et al., 2014; Sprague 
HW DO ZKLFK FRXOG EH OLQNHG WR RXU DJH SUR¿OH
(see below). In general, Asian women have consistently 
been reported to have higher density than other ethnic 
populations (del Carmen et al., 2007; Mariapun et al., 
2015) yet, the amount of women within the highest density 
category was unusually higher than that described for 
these other countries. Conversely, the overall proportion 
of high density (BI-RADS categories C and D) within 
the age groups was lower than those reported in other 
ethnic populations (Kim et al., 2000; Sprague et al., 
2014), suggesting a paucity of category C women. In 
particular, high density (C and D) was described for 31% 
of women in our study between the ages of 40 to 49 years 
old whilst this value was approximately 74% in USA and 
80 % in Korea for the same age category (Checka et al., 
2012; Youn et al., 2016). The variation may be due to 
GLIIHUHQFHVLQWKHVWXGLHVVDPSOHVKRZHYHUWKHLQÀXHQFH
of geographical location cannot be ruled out.
We examined age and body size, as two main 
determinants of MD. In agreement with other studies 
(McCormack and Silva, 2006; Checka et al., 2012), an 
overall inverse association between age and MD was 
LGHQWL¿HG KRZHYHU DJHGHQVLW\ UHODWLRQVKLSZDV YHU\
clear in our study with under 40 year olds having 6 
times higher density than over 40 year olds. It should be 
acknowledged that the mean age for women in our study 
is younger than that generally examined elsewhere in 
previous Western and Asian studies (Ellison-Loschmann 
et al., 2013; Youn et al., 2016). For example, the 
PDJQLWXGHRIRXU¿QGLQJZDVJUHDWHUWKDQWKHRGGVUDWLR
of 2 described in a recent Japanese study (Kawahara et 
al., 2013), however this latter comparison was for women 
under compared with over 45 year olds. Nonetheless, other 
causal factors for this large age-dependent change need to 
be considered. Firstly, the statistical method we employed 
could be a factor: unlike some of the previous work in 
our study, age was treated as a categorical variable which 
tends to provide systematically higher odds ratio (Lovasi 
et al., 2012) and although, odd ratios do not accurately 
characterize individuals’ risk (Pepe et al., 2004), as a 
method to identify the population risks, our approach is 
valid and has been used in numerous studies elsewhere. 
Secondly, this finding may actually be unique for 
Mongolian women. To our knowledge, this preliminary 
ZRUNLVWKH¿UVWVWXG\UHJDUGLQJEUHDVWGHQVLW\LQDODUJH
sample of Mongolian women, however, important factors 
of breast density peculiar to Mongolia such as lifestyle 
and reproductive factors (which were not available to us) 
need to be explored if we are to better understand causal 
DJHQWVIRUVSHFL¿FWHPSRUDODQGVSDWLDOGHQVLW\SDWWHUQV
and distributions. 
A greater weight and BMI were associated with lower 
MDs in our study which aligns well with the existing 
evidence across many populations (Boyd et al., 2006; 
Sung et al, 2010). However, consistent with some but 
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not all previous studies (Sellers et al., 2007; Boyd et al., 
2009; Dorgan et al., 2012), height showed a weak but 
VLJQL¿FDQW DVVRFLDWLRQZLWK0':KLOVW OHVV LV NQRZQ
regarding the relationship between this latter measure and 
breast density, some authors have investigated possible 
associations  and a direct relationship between the height 
in childhood and young adulthood and density has been 
previously shown (Dorgan et al., 2012; Andersen et al., 
6SHFL¿FDOO\WZRVWXGLHV%R\GHWDO'RUJDQ
et al., 2012) focusing on young women (15 to 30 years 
ROGGHPRQVWUDWHGDVLJQL¿FDQWKHLJKWGHQVLW\DVVRFLDWLRQ
which aligns reasonably well to the current paper 
particularly since the majority of women in our study 
were below 40 years old. The physiological mechanism 
underlying this association is unclear, however factors 
associated with breast development in early life such as 
increased growth hormone may mediate this association 
(Dorgan et al., 2012). The interaction between height of 
older adults and MD has not been previously investigated. 
We also compared women over and below 40 years old to 
identify any differences in determinant factors of MD and 
some subtle differences were noted, particularly related 
to patient weight. 
Geographical location appears to be an important 
indicator of variation in breast density. The present study 
provides evidence that women living in urban areas 
(Ulaanbaatar-UB) have higher MD than rural (non UB) 
women, although no differences was found within rural 
parts of Mongolia. This aligns with several studies which 
found positive associations between urbanization and 
breast density (Viel and Rymzhanova, 2012; Emaus et 
al., 2014; van der Waal et al., 2015) , the authors of which 
suggested that exposure to increased socio-economic 
status (SES) was at least in part responsible. Similarly, 
our data suggest that SES is an important causal agent 
since UB women tend to be more educated and more 
willing to adopt westernized culture than their rural 
counterparts (Dickson, 2012). In addition, as shown 
elsewhere, reproductive factors are probably contributing 
to this location discrepancy, since urban mothers are two 
times less likely to breastfeed for longer than 6 months 
compared to rural mothers in Mongolia (Dickson, 2012). 
However, the location density association shown in the 
XQLYDULDWHDQDO\VLVZDVQRWVLJQL¿FDQWDIWHUFRQWUROOLQJ
for age and body size. We should acknowledge that our 
study participants consisted mainly of urban women (90%) 
which may have impacted on the results. 
The main limitation of this study was the unavailability 
of information on important determinants of MD. For 
example, we were unable to collect comprehensive data 
on reproductive and lifestyle factors, all of which would 
have provided more thorough understanding of breast 
density risk factors. It could also be argued that BIRADS 
density assessment is an imperfect method since high 
rates of inter radiologist variability have been previously 
reported, however, this measure is the most widely used 
and accepted method in clinical practices and the only 
method to assess density used in Mongolia.  Furthermore, 
we successfully validated our BIRADS scores in a subset 
of 400 women with three breast radiologists demonstrating 
high inter-rater reliability. On a positive note, this study has 
IRUWKH¿UVWWLPHV\VWHPDWLFDOO\H[DPLQHGPDPPRJUDSKLF
density patterns among Mongolian women and since our 
study population was gathered from the National Cancer 
Center, the only cancer center in Mongolia, we can be 
fairly sure that most types of Mongolian women have 
been reasonably represented. 
In conclusion, this work has shown that age, body 
size and geographical location are key determinants of 
breast density among Mongolian women. The data from 
the work should be valuable to those health strategists 
exploring effective screening programs, however the link 
between breast density and breast cancer risk amongst 
WKLV SRSXODWLRQRIZRPHQQHHGV¿UVW WR EH HVWDEOLVKHG
DQGTXDQWL¿HG
&RQÀLFWRILQWHUHVW
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Acknowledgements
The student scholarship has provided by the Australian 
government.
References
AIHW (2014). Breast screening Australia, monitoring report, 
2011-2012. Australian institute of health and welfare, pp 57. 
Andersen ZJ, Baker JL, Bihrmann KIV, et al (2014). Birth 
weight, childhood body mass index, and height in relation to 
mammographic density and breast cancer: A register-based 
cohort study. BCR, 16, R4. 
Bertrand KA, Tamimi RM, Scott CG, et al (2013). Mammographic 
density and risk of breast cancer by age and tumor 
characteristics. BCR, 15, 6.
Boyd NF, Martin LJ, Sun L, et al (2006). Body size, 
mammographic density, and breast cancer risk. Cancer 
Epidemiol Biomarkers Prev, 15, 2086-92. 
Boyd NF, Guo H, Martin L, et al (2007). Mammographic density 
and the risk and detection of breast cancer. N Engl J Med, 
356, 227-36. 
Boyd NF, Martin LJ, Chavez S, et al (2009). Breast-tissue 
composition and other risk factors for breast cancer in young 
women: A cross-sectional study. Lancet Oncol, 10, 569-80. 
Checka CM, Chun JE, Schnabel FR, Lee J, Toth H (2012). The 
relationship of mammographic density and age: implications 
for breast cancer screening. AJR, 198, 292-5. 
Dai HJ, Yan Y, Wang PS, et al (2014). Distribution of 
PDPPRJUDSKLF GHQVLW\ DQG LWV LQÀXHQWLDO IDFWRUV DPRQJ
Chinese women. Int J Epidemiol, 43, 1240-51. 
del Carmen MG, Halpern EF, Kopans DB, et al (2007). 
Mammographic breast density and race. AJR, 188, 1147-50. 
Dickson I (2012). The Association between breastfeeding 
practices in Mongolia and geographical location of the 
mother and child (Master of public health thesis), University 
of Washington, pp 33.
Dorgan JF, Klifa C, Shepherd JA, et al (2012). Height, adiposity 
and body fat distribution and breast density in young women. 
BCR, 14, R107. 
Ellison-Loschmann L, McKenzie F, Highnam R, et al (2013). 
Age and ethnic differences in volumetric breast density in 
new zealand women: A cross-sectional study. PLoS One, 
8, e70217. 
Emaus MJ, Bakker MF, Beelen RMJ, et al (2014). Degree of 
urbanization and mammographic density in Dutch breast 
cancer screening participants: results from the EPIC-NL 
D Demchig et al
$VLDQ3DFL¿F-RXUQDORI&DQFHU3UHYHQWLRQ9RO2430
cohort. Breast Cancer Res Treat, 148, 655-63 
Freer PE (2015). Mammographic breast density: Impact on 
breast cancer risk and implications for Screening. Radio 
Graphics, 35, 302-15. 
.DZDKDUD06DWR6,GD<HWDO)DFWRUVLQÀXHQFLQJ
breast density in Japanese women aged 40-49 in breast 
cancer screening mammography. Acta Med Okayama, 67, 
213-17. 
Kim SH, Kim MH, Oh KK (2000). Analysis and comparison 
of breast density according to age on mammogram between 
Korean and Western Women. J Korean Radiol Soc, 42, 
1009-14. 
Lovasi GS, Underhill LJ, Jack D, et al (2012). At odds: Concerns 
raised by using odds ratios for continuous or common 
dichotomous outcomes in research on physical activity and 
obesity. Open Epidemiol J, 5, 13-7. 
Mariapun S, Li J, Yip CH, Taib NAM, Teo SH (2015). 
Ethnic differences in mammographic densities: An Asian 
cross-sectional study. PLoS One, 10, 2.
McCormack VA, Silva IDS (2006). Breast density and 
parenchymal patterns as markers of breast cancer risk: A 
meta-analysis. Cancer Epidemiol Biomarkers Prevent, 15, 
1156-69. 
3DFH/(.HDWLQJ1/$V\VWHPDWLFDVVHVVPHQWRIEHQH¿WV
and risks to guide breast cancer screening decisions. JAMA, 
311, 1327-35. 
Pepe MS, Janes H, Longton G, Leisenring W, Newcomb 
P (2004). Limitations of the odds ratio in gauging the 
performance of a diagnostic, prognostic, or screening marker. 
Am J Epidemiol, 159, 882-90. 
Sellers TA, Vachon CM, Pankratz VS, et al (2007). Association 
of childhood and adolescent anthropometric factors, physical 
activity, and diet with adult mammographic breast density. 
Am J Epidemiol, 166, 456-64. 
Sickles EA, D’Orsi CJ, Bassett LW (2013). ACR BI-RADS® 
Atlas, breast imaging reporting and data system. Retrieved 
from American college of radiology, 5, Changes; 4-9;14, 2.
Sprague BL, Gangnon RE, Burt V, et al (2014). Prevalence of 
mammographically dense breasts in the United States. J Natl 
Cancer Inst, 106, 10.
Sung J, Song YM, Stone J, Lee K, Kim SY (2010). Association 
of body size measurements and mammographic density in 
Korean women: the Healthy Twin study. Cancer Epidemiol 
Biomarkers Prev, 19, 1523-31. 
Troisi R, Altantsetseg D, Davaasambuu G, et al (2012). Breast 
cancer incidence in Mongolia. Cancer Causes Control, 23, 
1047-53. 
van der Waal D, Emaus MJ, Bakker MF, et al (2015). Geographic 
variation in volumetric breast density between screening 
regions in the Netherlands. Eur J Radiol, 25, 3328-37. 
Viel JF, Rymzhanova R (2012). Mammographic density and 
urbanization: A population-based screening study. J Med 
Screen, 19, 20-5. 
WHO (2013). Mongolia health system review, Health systems 
in transition, Vol 3, No 2, pp 15.
Youn I, Choi SH, Kook SH, Choi YJ (2016). Mammographic 
breast density evaluation in Korean women using fully 
automated volumetric assessment. J Korean Med Sci, 31, 
457-62. 
 
 
86 
Chapter 6 
 
 
Discussion 
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6.1  An overview of the thesis 
 
Breast cancer is the most prevalent cancer for females globally. Early-detected 
breast cancer enables effective treatment and therefore better patient outcomes are 
achievable. Amongst our early detection tools, mammographic screening (MS) is 
proven to be the most effective, reducing breast cancer mortality by up to 40% [1-3]. 
In developed nations, with the implementation of organised MS programs, breast 
cancer diagnoses have been transformed from a high proportion of advanced 
cancers to large numbers of early cancers such as DCIS [4, 5]. The reduction in the 
incidence of late stage diagnoses (T2 to T4) in Italy, for example, was shown from 
the 3rd year of implementation of MS program and to be as high as 20-30% by the 
eighth year [6]. Unfortunately, the majority of breast cancer patients in developing 
countries such as Mongolia where MS is currently unavailable are being diagnosed 
at late stages of the disease [7]. Also, incidence rates among developing countries 
are on the rise, whilst this figure remains stable in developed countries. It is therefore 
important for developing countries to identify an effective but affordable strategy for 
early detection of breast cancer particularly when self and clinical examinations have 
not been proven to reduce mortality and are considered inadequate as a screening 
tool [1].  
 
Although, the incidence rate for breast cancer in Mongolia appears to be low when 
compared globally, the large proportion (90%) of advanced diagnoses along with a 
consistent increase of incidence highlight the need to initiate early detection 
strategies [8, 9]. The increase in incidence rate of breast cancer in Mongolia has also 
been previously noticed between 1998 and 2005 [8]. However, consistent increase in 
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incidence rate of breast cancer in Mongolia may not be significant, since we 
observed the data covering short period of time between 2009 and 2013. This may 
be caused by the natural fluctuation of the short-term data and therefore long period 
of observation is necessary. As a country with limited economic and health care 
resources, starting an organised MS program is currently unrealistic in Mongolia but 
tailored MS, targeting high risk women may help to decrease delayed diagnoses, 
particularly since mammographic facilities operate in the country. However the 
effectiveness of mammography is unknown in Mongolia, particularly since the 
density characteristics of Mongolian women are poorly understood. As 
mammography is the front-line tool for breast cancer diagnoses, its accuracy is 
critically important. However, detecting breast lesions on a mammogram is a 
challenging task for radiologists and therefore approximately 30% of cancers are not 
reported during screening examinations [10]. On the other hand, mammographic 
breast density (MD) is a strong and independent risk factor for breast cancer and a 
key determinant for mammographic efficacy. Unfortunately, information around 
radiologist efficacy or mammographic density is unavailable in Mongolia. Without this 
information, mammographic efficacy will remain unclear, which will likely to 
contribute to poor patient outcomes in Mongolia.  
 
This PhD thesis, to our knowledge, is the first study that was specifically designed to 
provide specific information that would help in establishing a screening program in 
Mongolia, particularly by investigating interpretive accuracy of radiologists in reading 
mammograms and characteristics of MD. With this information, we will be able to 
understand the effectiveness of mammography in Mongolia which will further help to 
optimize screening approaches specific to these women.  
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The objectives of this study are:  
 
1) To publish a literature review in an international peer-reviewed journal to 
identify the overall status of breast cancer in Mongolia in terms of incidence, 
mortality, survival features along with information of risk factors and breast 
cancer screening; 
 
2) To investigate radiologists’ accuracy in reading screening mammograms 
using two different test-sets with deliberately different levels of difficulty; 
 
3) To examine the distribution of MD for Mongolian women and its relationship 
with age, body mass index and area of residency using the density categories 
of BI-RADS 5th edition. 
 
By involving over 80% of national breast readers and a large number of 
mammograms (n=1985) for MD evaluation, the current thesis provides new 
knowledge around mammographic diagnostic accuracy and MD features in 
Mongolia. In chapter 3 and 4, the performance of the Mongolian radiologists in 
reading mammograms was assessed using a standard mammographic test-set 
(BREAST [11]). The Australia based initiative, BREAST [11] is a well-known platform 
for testing radiologists’ performance not only in Australia but also internationally such 
as Vietnam, Singapore, Iran, Italy and Jordan. These two studies provided a detailed 
understanding of radiologists’ diagnostic accuracy in reading mammograms in 
Mongolia.  
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In other to accurately measure the level of performance, we first used the difficult 
image-set (chapter 3), because this was a standard test-set in Australia and New-
Zealand to measure and monitor mammographic performance of radiologists and 
this was called the high difficulty (HD) test-set. These images were sourced from the 
Australian screening images by specifically including mammograpms with early 
cancer findings such as stellates and architectrual distortions that were missed by 
one radiologist. In Australia, double reading strategy applies for breast screening 
programs and a third reader is involved when two readers disagree in their decision.  
 
However, since results of Mongolian radiologists were far lower than those observed 
among Australian radiologists and considering the lack of screening practice in 
Mongolia and difficutly of the images used in the previous study, we then decided to 
reduce image difficulty in the second study. This was called the typical screening 
(TS) test-set (chapter 4), since we feel it represented better typical mammographic 
screening case difficulty. Unlike the HD test-set, cancer image difficulty was reduced 
in the TS test-set by only including the images with more that 80% sensitivity scores 
which was based on the performance data of 311 Australian readers. Normal images 
in this test-set were randomly selected from the normal image bank which was 
previously proven to be cancer free and re-validated by three radiologists to be 
represent as typical normal images within the screeing environment.  
 
In chapter 5, MD was explored for Mongolian women and mammograms were 
collected from the National Cancer Centre of Mongolia (NCC). For the MD 
assessment, the 5th edition of breast imaging reporting and data system (BI-RADS) 
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categories were used [12]. This study was performed in a geographically diverse 
population within the country, since the NCC is the only cancer institution nationwide 
and generalizability of the study is therefore fairly reasonable. Although the BI-RADS 
density assessment is a subjective method, it is currently the most commonly used 
approach amongst radiologists. In the present study, breast density was assessed 
by the experienced radiologist with more than three years of screen reading 
experience in Australia. To validate density assessment of the radiologist, the three 
breast radiologists from both Mongolia and Australia read a sub-set of 400 
mammograms and a high inter-rater reliability (ICC=0.91, 95% CI: 0.90-0.93) was 
found between these readers. In addition, age; BMI and area of residency, which are 
the important predictors for MD, were examined along with MD.  
 
6.2  Significant findings 
 
The thesis set out to explore mammographic diagnostic accuracy and characteristics 
of MD that would help in establishing of a breast-screening program in Mongolia. 
The objectives listed earlier were achieved. First, the literature review was published 
in Breast Cancer: Targets and Therapy (a peer-reviewed journal) which identified the 
epidemiological characteristics of breast cancer in Mongolia and the differences 
between the Asian and Westernised world [13]. It became evident from the literature 
review that advanced disease presentation played an essential role in reducing good 
patient outcomes whilst the incidence of breast cancer is consistently increasing in 
Mongolia. 
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Second, radiologists’ accuracy in reading mammograms was explored with two 
studies. The first was conducted with the high difficulty test-set, which included 60 
mammographic cases. This work involved 11 and 52 breast radiologists from 
Mongolia and Australia respectively. The aim of this work was to identify the level of 
diagnostic accuracy of Mongolian radiologists and it was found to be low for all 
measured metrics. Particularly, it was shown that, with only 26% lesion sensitivity, 
locating the lesion was the most difficult task for the Mongolian radiologists. With the 
typical (less difficult) test-set, again including 60 mammographic cases, the second 
study re-tested the performance of these readers. Whilst the same participants from 
Mongolia (n=11) read the cases, performance data of different 101 Australian 
readers were used to compare the accuracy metrics in the second study. This work 
confirmed the existence of low interpretive accuracy of radiologists in reading 
mammograms in Mongolia. Again the location sensitivity (38%) was the worst 
accuracy metric for the Mongolian radiologists. 
 
 It is interesting to note that average specificity (77%) for both test-sets was the 
parameter in which the Mongolian radiologists scored highest. However, specificity 
can only be valuable when sensitivity is also high [14], since high specificity with low 
sensitivity implies a low operating point on the ROC curve and therefore, despite this 
relatively high recognition of normal images, overall the metrics for Mongolian 
radiologists suggest poor performance. Whilst little is known about the 
mammographic performance of radiologists from developing countries like Mongolia, 
our findings were consistent with some studies which demonstrated better 
performances amongst Australian breast radiologists compared with those in 
Singapore and Vietnam [15, 16]. Nonetheless, it should be noted that the vast 
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majority of the existing literature on radiologists’ performance was conducted in 
developed countries, where breast screening is well established.  
 
The third study investigated MD features for women in Mongolia. When two 
categories of MD classification were considered, the proportion of low MD was more 
prominent (58%) than high MD (42%) for women in Mongolia. However, when taking 
the 4-grades of MD classification into account, the proportion of category 4 
(extremely dense) was noticeably high (24%), whilst the majority of women (33%) 
were allocated to the category 2 (scattered areas of fibroglandular density). These 
results are closer to the previous findings for both Western and Asian studies, which 
showed an overall equal distribution of MD between low and high-density categories 
[17, 18]. However, less agreement in age-specific density distribution between our 
study and the previous Asian studies were noted; the proportion of high density for 
women aged over 40 years old was much higher among Korean [19] and Chinese 
women [20] than ours and while the later demonstrated the discriminatory age 
between high and low density as 55 years old whilst this figure found to be 40 in our 
study. Our finding of the high proportion of low-density breasts among women above 
40 years old (85%) as opposed to high density may be an indicative of the potential 
for using mammography for population screening in Mongolia. In addition, the 
purpose of this study was to identify the factors associated with breast density. 
Whilst the positive association was found between age and BMI and MD, 
relationship between area of residency and MD was not strong for women in 
Mongolia. Due to the lack of MD studies arising from Mongolia, we were unable to 
compare our result within Mongolian setting however, these findings were aligned 
with the existing literature elsewhere [21, 22].  
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6.3  Implications  
 
The thesis provides useful information required for optimizing a national program for 
early detection of breast cancer in Mongolia and has two major implications. The first 
implication is that for the first time, we demonstrated the need for improving early 
detection of breast cancer in Mongolia. Breast cancer diagnosis in Mongolia has 
been shown to be less than optimal with radiology performance measures being 
substantially lower than those in countries such as Australia, Singapore and Vietnam 
[15]. Although there are several causal factors, lack of training in breast imaging 
plays a key role. Effective training and ongoing clinical practice can develop these 
skills, however in Mongolia, it is difficult to achieve proper knowledge and skills 
under the current 2-years radiology residency program which does not include a 
subspecialty training in breast imaging. This is in contrast to the 5-years training 
program in many countries [23, 24] where better performance of readers is reported 
[25]. Since early diagnosis and better patient outcome are heavily reliant on accurate 
radiologists’ interpretation of breast images, a radiology educational program such 
as BREAST [11] should be implemented in Mongolia. This may assist improving the 
health outcomes for Mongolian women with breast cancer through more accurate 
and earlier diagnosis. In particularly, BREAST has been shown to be effective 
strategy for enhancing reader accuracy in mammography and up to 34% of 
improvement was found for radiologists who regularly participated in BREAST 
workshops [26]. Therefore, we strongly recommend such types of learning activity in 
Mongolia so that optimal performance can be achievable. Meanwhile however, 
teleradiology may have potential to facilitate the reading of mammograms during 
transition period of local radiologists are being up skilled.  
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The second implication is that by providing a comprehensive understanding of MD 
amongst Mongolian women, we can start optimising screening methods. In 
particular, our findings coupled with previous evidence suggest that MS may have 
potential in Mongolia for early detection since majority of screening age women (>40 
years old) were found to have low density breasts. In particular in our study, the 
percentage of high density across the age groups were found to be low when 
compared with other Asian nations [17, 27]; for example with only 13% high density, 
women aged 40-49 may be good candidates for MS in Mongolia, whilst this age 
group in other countries has usually been found to have a large number of dense 
breasts, which limits mammography screening implementation [28]. However, prior 
to establishing a screening program, it would be important to explore the association 
between MD and breast cancer risk amongst Mongolian women so that an 
appropriate screening method can be chosen. It is also necessary to verify MD 
distribution amongst Mongolian women along with causal factors such as hormonal 
and lifestyle status (which were not available to us).  
 
In this discussion it is worth acknowledging the high proportion of women with 
extremely dense breasts that was reported in our study. For these specific women, it 
may be necessary to consider supplementary ultrasound examination; however, 
85% of women in this category were aged below 40 years old and therefore, specific 
screening approaches may not be necessary, since this age group is currently not 
recommended for breast cancer screening. Overall however, it should be noted that 
almost 80% of women in our study were aged below 50 years old and the mean age 
(40 years old) was younger than that usually investigated elsewhere and of note is 
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that the majority of women in their 40s in our study was found to have low density 
breasts. This is in contrast to the data arising from other Asian studies, where a 
much higher prevalence of high density for this age group was noted, which has 
added to the debate around the optimum imaging modality in Asia [29, 30].  
 
The images was obtained from the National Cancer Centre of Mongolia, which is the 
only cancer centre in the country where breast cancer patients are provided by 
diagnostic and treatment services. Therefore, the data should reasonably cover all 
types of women including screening population. Although other screening method 
such as self and clinical breast examinations are recommended in Mongolia, these 
methods are having limited impact on detection of early breast cancers and therefore 
mammography will likely to remain on front line tool for breast cancer diagnosis. 
Based on our findings therefore, mammography appears to be the effective 
screening approach in Mongolia especially considering the peak age of breast 
cancer incidence for Mongolian women (45-49 years old), although advantage of 
using mammography for screening purposes requires further studies.  
 
Mongolia remains to have low incidence rate of breast cancer, which limits the 
implementation of screening program since low incidence disease does not qualify to 
require early detection program.  However, with consistent increase in incidence and 
advanced disease presentation, it is necessary to discuss early detection approach 
for breast cancer in Mongolia. When the national guideline was proposed in 2012, 
Mongolia had limited mammographic facilities but nowadays, this technique has 
become more common in practice and hence mammography could be considered 
for screening purposes. However, running a screening approach involving all women 
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routinely is expensive and not recommended for low resource countries like 
Mongolia.  
 
In consideration of the current low rate of incidence, tailored screening approach, 
targeting high-risk women may have potential to reduce breast cancer mortality in 
the country. Indeed, risk factors for breast cancer vary by multiple factors including 
ethnicity, cancer biology and environmental factors. It is therefore extremely 
important to identify risk factors specific to Mongolian population in other to correctly 
classify women into high-risk group. According to the national study [9], early 
menarche, nulliparity and obesity were the risk factor for developing breast cancer 
for Mongolian women however; the level of association was unclear. Given with the 
limited information on risk factors in Mongolia, risk assessment could be based on 
the well-established risk factors including family and high breast density. 
Nonetheless, risk factors, contributing to develop invasive breast cancer among 
Mongolian women remain unclear, which suggest that implementation of screening 
program could be misleading and unnecessary at the present time. 
 
6.4  Limitations  
 
The three studies outlined here have provided new knowledge of radiologists’ 
diagnostic accuracy in mammography and characteristics of MD in Mongolia. 
However, we cannot rule out some of possible limitations that have impacted upon 
our findings. 
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In the first two studies (chapter 3 and 4), the small number of radiologists in each 
group resulted in limited statistical power. Therefore for example, due to there only 
being 11 radiologists within our Mongolian readers, we were not able to observe 
relationships between reader characteristics such as number of mammograms read 
per year and number of years since the qualification of radiologist and accuracy 
metrics, in contrast to the findings from other studies [14, 25]. However, recruiting 
radiologists into the experimental study was very difficult and after much effort we 
can confidently say that we involved 80% of national breast readers, indicating that 
our findings must at least reasonably demonstrate the actual level of mammographic 
performance existing in Mongolia. Moreover, it may seem to be unrealistic to 
compare the screening performance of Mongolian radiologists with Australian 
readers due to the wide variations in cancer (high and low prevalence settings in 
Australia and Mongolia) and reader (radiology training, clinical experience and 
practice volume) associated factors, which all can have impact on reader 
performance. It can also be argued that the well-established screening practice in 
Australia since 1991 [31] allowed Australian radiologists to develop skills required in 
image interpretation, whilst this opportunity does not exist in Mongolia. However, 
quality diagnostic imaging service should be available for cancer patients regardless 
of their geographical locations.   
 
Another limitation is around the fact that mammograms used were sourced from 
Australia and may have resulted in a higher number of false negatives amongst the 
Mongolian radiologists due to their lack of experience in dealing with such a cohort of 
women. Specifically, breast morphology (breast density) differs by ethnicity and 
therefore Australian mammograms can be different from Mongolian mammograms, 
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but demonstrated variations of breast density in literature between different 
populations appear to be fairly small and therefore less likely to affect in a massive 
way reader performance [27, 32]. In addition, type of breast lesions presenting in 
Australia vary greatly than those occur in Mongolia, which could be understood rare 
features for Mongolian radiologists and therefore may impact on decision making of 
Mongolian radiologists (prevalence effect) [33]. However, the standard test-sets used 
for testing and monitoring reader performance in Australia and New Zealand and the 
validated research method used in the current study minimised the impact of image 
bias. Also, comparisons have shown that actual clinical performance can reasonably 
be predicted with test-set images (used in our study), suggesting the validity of our 
results [34].      
 
In the third study (chapter 5), information around important determinants of MD such 
as reproductive (menopausal and parity status), and lifestyle factors (smoking and 
alcohol consumption) were noticeably absent. These factors could have helped our 
understanding of causal agents responsible for MD variations for women in 
Mongolia. However in Mongolia, patient and clinical information are recorded in an 
individual-based medical file, which is kept with patients, causing a challenge in 
collecting research data. Nonetheless, this information can be obtained with a 
dedicated survey questionary when the patient undergoes mammographic 
examination. In addition, it may be argued that breast density assessment (BI-
RADS) is as an imperfect method for assessing breast density since it has wide 
inter- and intra- reader variability [35]. But, the BI-RADS is the most widely used and 
accepted method among radiologists in clinical practice and the only available 
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method to assess the breast density in Mongolia. Also, in our study, three 
radiologists validated density scores from the BI-RADS method.  
 
6.5  Future directions  
 
From the limitations mentioned above, it is clear that future work should be designed 
to address those deficiencies. First, testing reader performance with Mongolian data 
(mammograms) would have helped to better understand the interpretive accuracy of 
radiologists in reading mammograms. This is particularly important since we used 
Australian screening images, which is uncommon practice for Mongolian radiologists 
[36]. Therefore, our findings have raised a question whether the readings of familiar 
images (Mongolian mammograms) by Mongolian radiologists would be different from 
their readings of Australian images. It would be interesting to know such differences, 
which would further provide information to establish sophisticated strategic solutions 
such as educational intervention, clinical auditing and administrative regulations.  
 
Second, whilst our MD study demonstrated interesting and valid information, this 
should now be confirmed using objective methods such as area based approaches 
(Cumulus and Auto Density) and volumetric software tools (VolparaTM and 
QuantraTM). It will be helpful to know the prediction of density status in Mongolia with 
these methods since the evidence from Westernised populations, using automated 
methods showed that the estimation of breast density can be more robust and 
precise than assessed subsequently by radiologists (BI-RADS) [37]. It is also 
important to investigate factors (as mentioned in the previous paragraph) influencing 
MD, because these are not only determinants for MD but also contribute to breast 
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cancer risk [38]. Thus, we would have a better understanding of aetiology of the 
disease specifically for Mongolian women. This could be achieved by a well-
designed research method with survey questionaries involving women who undergo 
mammography either for screening or diagnostic purposes.  
 
Finally, in the current work, the link between breast cancer and high MD was not 
explored due to the lack of cancer images from Mongolia. As high MD is not only a 
risk for developing breast cancer but also determinant of mammographic sensitivity, 
the identification of MD risk for Mongolian women would have two important 
outcomes: first, it would help to improve our understanding of breast cancer 
aetiology; second, prevention strategies of the disease can be facilitated with 
individual-based screening recommendation. At the present time, cancer image 
collection from Mongolia is challenging because of the lack of electronic hospital 
systems at the NCC. Although, biopsy proven cancer cases can be obtained 
retrospectively from the paper-based archive, it is unlikely that the associated 
images will be readily available and therefore patients need to be recalled bringing 
their mammograms with them. Despite this complicated process for retrieving cancer 
images, it can be achievable prospectively with a cleverly designed method involving 
pathology and radiology departments as well as consumer representatives. 
 
6.6  The way forward in Mongolia 
 
Although mammography appears to be a suitable modality for breast screening in 
Mongolia, we found that mammographic diagnostic accuracy was sub-optimal with a 
cancer sensitivity of 54% that needs to be addressed urgently. What is more 
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worrying is that lesion sensitivity ranges from 26-38% which may contribute to 
continued poor patient outcomes if immediate strategy to improve reader accuracy in 
mammography is not initiated.  
 
Having seen how quality mammographic services play essential roles in breast 
cancer diagnosis in Australia and how challenging the diagnostic service is in my 
home country, Mongolia, it is clear that continuing medical education is critically 
important for professional development. However, this type of training specific to 
mammography is not often available in Mongolia, therefore I believe it is necessary 
to set up a non-governmental organisation (NGO) that will enable me to lead the 
educational needs required for early cancer diagnoses.  
 
We have successfully registered the NGO, radiology education centre (RE: centre) in 
April 2018 in Mongolia. The main function of the RE: centre will be working on 
devising postgraduate educational programs including online and local teaching 
courses, to enhance radiologists’ ability to diagnose early cancers. We have 
proposed the first project, BREAST Mongolia: Transforming breast cancer detection 
in Mongolia and to support this activity we have applied for two grants funded by the 
Australian and Canadian governments.  
 
BREAST Mongolia will be a robust educational program including a teaching course 
and interactive online assessment platform to enhance the quality of breast cancer 
diagnosis in the country. The project will be based on BREAST [11] currently 
employed in Australia which demonstrated to contribute to improved diagnostic 
performance of radiologists [26]. We have a world-class collaboration in place to 
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deliver this project: Professor Patrick C Brennan, a world expert on testing radiologist 
performance; Professor Mary Rickard, a global leader in breast imaging education 
and Professor Asai Ramish, Chief Radiologist at the National Cancer Centre of 
Mongolia, who will ensure maximum Mongolian radiologist engagement.  
 
We hope BREAST is specifically important in Mongolia because mammographic 
training does not exist in the country and without such training it is unlikely that 
radiologists develop necessary skills required in mammographic interpretation, in 
particularly with a low incidence setting. In addition, the NGO will not only work for 
breast specific projects, we will be focusing on other areas of radiology such as 
chest and abdominal imaging, since currently specialist professional training in 
radiology is not available in Mongolia. To ensure maximum engagement of 
radiologists, we will closely collaborate with the public hospitals along with the 
private clinics. However the main collaborator of the NGO will be the National 
Cancer of Mongolia since this the only cancer specialised hospital nationwide, where 
cancer diagnoses and treatments are available.  
 
6.7  Conclusion 
 
This work has explored mammographic diagnostic performance of radiologists and 
MD features in Mongolia, which are important factors for establishing strategies for 
early detection of breast cancer. First, the study found the existence of sub-optimal 
mammographic diagnostic accuracy, suggesting an urgent need to initiate a strategic 
solution to maximise early cancer diagnosis. At the present time, this is a very 
important issue since breast cancer has subjected Mongolia to a heavy health 
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service burden due to the high proportion of advanced cancer diagnoses. Second, 
distribution of low-density breasts has found to be predominant in Mongolia, which is 
a good indicator for mammographic screening efficacy. This study also showed that 
age and body mass index were the main determinants for varying level of MD in 
Mongolia.  
 
Whilst our findings are in line with what has been previously known about the 
mammographic diagnostic accuracy and MD characteristics in other countries, a 
number of findings were unique to Mongolia. The data provided in the thesis should 
be useful in optimising national screening program and cancer prevention policy and 
presents important information for clinicians, researchers and policy makers in 
Mongolia. However, future work is necessary to develop the current evidence of 
mammographic performance and MD features for Mongolian women. 
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Appendix 1.1 
 
Ethical approval – The University of Sydney 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Research Integrity 
Research Portfolio 
Level 6, Jane Foss Russell 
The University of Sydney  
NSW 2006 Australia 
T +61 2 8627 8111 
F +61 2 8627 8177 
E ro.humanethics@sydney.edu.au 
sydney.edu.au 
ABN 15 211 513 464 
CRICOS 00026A 
 
 
Research Integrity 
Human Research Ethics Committee 
 
 
 
Wednesday, 17 December 2014 
 
 
Assoc Prof Claudia Mello-Thoms 
Medical Imaging and Radiation Sciences; Faculty of Health Sciences 
Email: claudia.mello-thoms@sydney.edu.au 
 
 
 
Dear Claudia 
 
I am pleased to inform you that the University of Sydney Human Research Ethics Committee (HREC) 
has approved your project entitled “Characterizing breast density and breast cancer amongst 
Mongolian women”.  
 
 
Details of the approval are as follows: 
 
Project No.:  2014/973 
 
Approval Date:  16 December 2014  
 
First Annual Report Due: 16 December 2015  
 
Authorised Personnel: Mello-Thoms Claudia; Brennan Patrick; Demchig Delgermaa; 
 
 
HREC approval is valid for four (4) years from the approval date stated in this letter and is granted 
pending the following conditions being met: 
 
Condition/s of Approval 
 
x Continuing compliance with the National Statement on Ethical Conduct in Research Involving 
Humans.  
 
x Provision of an annual report on this research to the Human Research Ethics Committee from 
the approval date and at the completion of the study. Failure to submit reports will result in 
withdrawal of ethics approval for the project.  
 
x All serious and unexpected adverse events should be reported to the HREC within 72 hours. 
 
x All unforeseen events that might affect continued ethical acceptability of the project should be 
reported to the HREC as soon as possible. 
 
x Any changes to the project including changes to research personnel must be approved by the 
HREC before the research project can proceed.  
 
x Note that for student research projects, a copy of this letter must be included in the 
candidate’s thesis. 
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Chief Investigator / Supervisor’s responsibilities: 
 
1. You must retain copies of all signed Consent Forms (if applicable) and provide these to the HREC 
on request. 
 
2. It is your responsibility to provide a copy of this letter to any internal/external granting agencies if 
requested. 
 
 
Please do not hesitate to contact Research Integrity (Human Ethics) should you require further 
information or clarification. 
 
Yours sincerely 
 
Professor Glen Davis 
Chair 
Human Research Ethics Committee 
 
 
 
This HREC is constituted and operates in accordance with the National Health and Medical 
Research Council’s (NHMRC) National Statement on Ethical Conduct in Human Research 
(2007), NHMRC and Universities Australia Australian Code for the Responsible Conduct of 
Research (2007) and the CPMP/ICH Note for Guidance on Good Clinical Practice. 
 
 Research Integrity 
Research Portfolio 
Level 6, Jane Foss Russell 
The University of Sydney  
NSW 2006 Australia 
T +61 2 8627 8111 
F +61 2 8627 8177 
E ro.humanethics@sydney.edu.au 
sydney.edu.au 
ABN 15 211 513 464 
CRICOS 00026A 
 
 
Research Integrity 
Human Research Ethics Committee 
 
 
 
Thursday, 2 June 2016 
 
 
Prof Patrick Brennan 
Medical Imaging and Radiation Sciences; Faculty of Health Sciences 
Email: patrick.brennan@sydney.edu.au  
 
 
 
Dear Patrick 
 
I am pleased to inform you that the University of Sydney Human Research Ethics Committee (HREC) 
has approved your project entitled “Radiologist performance on ethically different databases.”.  
 
Details of the approval are as follows: 
 
Project No.:  2016/406 
 
Approval Date:  1 June 2016  
 
First Annual Report Due: 1 June 2017 
 
Authorised Personnel: Brennan Patrick; Mello-Thoms Claudia; Demchig Delgermaa 
 
Documents Approved:  
 
Date Type Document 
27/05/2016 Participant Info Statement Participant information statement 
23/05/2016 Participant Consent Form Amended PCF 
 
 
HREC approval is valid for four (4) years from the approval date stated in this letter and is granted 
pending the following conditions being met: 
 
Condition/s of Approval 
 
x Continuing compliance with the National Statement on Ethical Conduct in Research Involving 
Humans.  
 
x Provision of an annual report on this research to the Human Research Ethics Committee from 
the approval date and at the completion of the study. Failure to submit reports will result in 
withdrawal of ethics approval for the project.  
 
x All serious and unexpected adverse events should be reported to the HREC within 72 hours. 
 
x All unforeseen events that might affect continued ethical acceptability of the project should be 
reported to the HREC as soon as possible. 
 
x Any changes to the project including changes to research personnel must be approved by the 
HREC before the research project can proceed.  
 
 Page 2 of 2 
 
x Note that for student research projects, a copy of this letter must be included in the 
candidate’s thesis. 
 
Chief Investigator / Supervisor’s responsibilities: 
 
1. You must retain copies of all signed Consent Forms (if applicable) and provide these to the HREC 
on request. 
 
2. It is your responsibility to provide a copy of this letter to any internal/external granting agencies if 
requested. 
 
 
Please do not hesitate to contact Research Integrity (Human Ethics) should you require further 
information or clarification. 
 
Yours sincerely 
Associate Professor Rita Shackel 
Chair 
Human Research Ethics Committee (HREC 3) 
 
 
 
This HREC is constituted and operates in accordance with the National Health and Medical 
Research Council’s (NHMRC) National Statement on Ethical Conduct in Human Research 
(2007), NHMRC and Universities Australia Australian Code for the Responsible Conduct of 
Research (2007) and the CPMP/ICH Note for Guidance on Good Clinical Practice. 
 
 Research Integrity & Ethics Administration 
Research Portfolio 
Level 2, Margaret Telfer Building (K07) 
The University of Sydney  
NSW 2006 Australia 
T +61 2 9036 9161 
E human.ethics@sydney.edu.au 
W sydney.edu.au/ethics 
ABN 15 211 513 464 
CRICOS 00026A 
 
 
Research Integrity & Ethics Administration 
Human Research Ethics Committee 
 
Friday, 21 July 2017 
 
 
Prof Patrick Brennan 
Medical Radiation Sciences; Faculty of Health Sciences 
Email: patrick.brennan@sydney.edu.au 
 
 
Dear Patrick, 
 
Your request to modify this project, which was submitted on 26th April 2017, has been considered.  
 
After consideration of your response to the comments raised the project has been approved to 
proceed with the proposed amendments. 
 
Details of the approval are as follows: 
 
Project Title: Radiologist performance on ethically different databases. 
 
Project No.: 2016/406 
 
Next Annual Report due:  1st June 2018 
 
New Approved Documents: 
 
Date Uploaded Type Document Name 
19/06/2017  Participant Info Statement  PIS  
19/06/2017  Participant Info Statement  PIS  
 
 
Special Condition/s of Approval 
 
x There are a couple of minor formatting issues in both of the PIS documents provided (e.g. 
section title and content on separate pages, missing line breaks between bullet point list and next 
paragraph). If the CI decides to address these, he is requested to provide a final copy of the 
amended documents to the Ethics Office. 
 
Please contact the Ethics Office should you require further information or clarification. 
 
Sincerely, 
 
Dr Jim Rooney 
Chair 
Modification Review Committee 
 
The University of Sydney HRECs are constituted and operate in accordance with the National 
Health and Medical Research Council’s (NHMRC) National Statement on Ethical Conduct in 
Human Research (2007) and the NHMRC’s Australian Code for the Responsible Conduct of 
Research (2007). 
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Appendix 1.2 
 
Ethical approval – The Ministry of Health, Mongolia 
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Appendix 1.3 
 
Data collection approval – National Cancer Centre of Mongolia 
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Appendix 1.4 
 
Data collection approval - BREAST 
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Appendix 1.5 
 
Participant information sheet 
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Discipline of Medical Radiation Science 
Faculty of Health Sciences 
  
 ABN 15 211 513 464 
 
  Professor. Patrick Brennan 
 Professor of Diagnostic Radiography  
 
Room 221 
M Building C42 
Cumberland Campus 
The University of Sydney 
PO box 170 Lidcombe  
NSW 2006 AUSTRALIA 
Telephone:   +61 2 90367402 
Facsimile:  +61 2 90367402 
Email: Patrick.brennan@sydney.edu.au 
Web: http://www.sydney.edu.au/ 
 
Radiologist performance on ethically different populations 
 
PARTICIPANT INFORMATION STATEMENT 
 
(1) What is this study about? 
 
You are invited to take part in a research study about the radiologist performance when interpreting 
ethnically different data sets. The study compares readers’ performance using two data sets, which 
involving 60 mammograms respectively. This proposed research is expected to provide knowledge 
around the diagnostic accuracy and variability among radiologists. Based on our results, we will 
develop training modules which will contribute to improving the quality of breast cancer diagnosis and 
help to improve detection rate of early cancer in Mongolia.  
 
You have been invited to participate in this study because you are a radiologist. This Participant 
Information Statement tells you about the research study. Knowing what is involved will help you 
decide if you want to take part in the research. Please read this sheet carefully and ask questions about 
anything that you don’t understand or want to know more about.  
 
Participation in this research study is voluntary. So it’s up to you whether you wish to take part or not.  
By giving your consent to take part in this study you are telling us that you: 
 
9 Understand what you have read. 
9 Agree to take part in the research study as outlined below. 
9 Agree to the use of your personal information as described. 
 
You will be given a copy of this Participant Information Statement to keep. 
 
(2) Who is running the study? 
 
 The study is being carried out by the following researchers: 
x Prof Patrick C Brennan (Professor of Diagnostic Radiography) 
x Prof Claudia Mello-Thoms (Associate Professor of Diagnostic Radiography) 
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x Dr Delgermaa Demchig (HDR Student, The University of Sydney) 
 
 Dr Delgermaa Demchig is conducting this research for the Degree of Doctor of Philosophy at the 
University of Sydney. This will take place under the supervision of Professors Patrick Brennan and 
Mello-Thoms.  
 
(3) What will the study involve for me? 
 
In this study, you will be asked to interpret two data sets; each consists of 60 mammograms. The 
reading section will be divided into two parts and you will be expected to evaluate each 
mammogram using the Breast Imaging Reporting and Data System (BI-RADS) categories. Each 
mammographic case contains medio-lateral oblique (MLO) and craniocaudal (CC) views as a 
standard. During each reading section, you will identify and localize every abnormality within the 
digital mammograms.  
 
(4) How much of my time will the study take? 
 
Each reading section will take approximately 1.5-2 hours to complete. Altogether, 3-4 hours will be 
required to complete the work.   
 
(5) Who can take part in the study? 
 
This study is open to all breast readers (radiologists) in Mongolia who are involved in interpreting 
mammography.  
 
(6) Do I have to be in the study? Can I withdraw from the study once I've started? 
 
Being in this study is completely voluntary and you do not have to take part. Your decision whether 
to participate will not affect your current or future relationship with the researchers or anyone else 
at the University of Sydney and Hospitals in Mongolia.  
 
If you decide to take part in the study and then change your mind later, you are free to withdraw at 
any time. You can do this by sending an email to ddem2574@uni.sydney.edu.au. Any collected data 
will be also deleted, should you choose to withdraw from the study at any later stage.  
 
(7) Are there any risks or costs associated with being in the study? 
 
Aside from giving up your time, we do not expect that there will be any risks or costs associated with 
taking part in this study. 
 
(8) Are there any benefits associated with being in the study? 
 
  You will not receive any direct benefits from being in the study. 
 
(9) What will happen to information about me that is collected during the study 
 
Your information will be stored securely and your identity/information will be kept strictly 
confidential. Study findings may be published, but you will not be individually identifiable in any 
publication.   
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We will keep the information we collect for this study. We will only use the data for our current study. 
If we do need to use the data for a future study, we will seek appropriate ethical approval before 
using the information.  
 
By providing your consent, you are agreeing to us collecting personal information about you for the 
purposes of this research study. Your information will only be used for the purposes outlined in this 
Participant Information Statement, unless you consent otherwise. 
 
(10) Can I tell other people about the study? 
 
 Yes, you are welcome to tell other people about the study. 
 
(11) What if I would like further information about the study? 
 
When you have read this information, Dr Delgermaa Demchig or Prof Patrick Brennan will be 
available to discuss it with you further and answer any questions you may have. If you would like to 
know more at any stage during the study, please feel free to contact Dr Delgermaa Demchig (HDR 
Student in Medical Radiation Science) at ddem2574@uni.sydney.edu.au or Prof Patrick Brennan 
(Professor of Diagnostic Radiography) at Patrick.brennan@sydney.edu.au or +61 2 90367402. 
 
(12) Will I be told the results of the study? 
 
You have a right to receive feedback about the overall results of this study. You can tell us that you 
wish to receive feedback by emailing us at Patrick.brennan@sydney.edu.au. This feedback will be in 
the form of word document summary. You will receive this feedback after the study is finished. 
  
 
(13) What if I have a complaint or any concerns about the study? 
 
Research involving humans in Australia is reviewed by an independent group of people called a 
Human Research Ethics Committee (HREC). The ethical aspects of this study have been approved by 
the HREC of the University of Sydney [INSERT protocol number once approval is obtained]. As part of 
this process, we have agreed to carry out the study according to the National Statement on Ethical 
Conduct in Human Research (2007). This statement has been developed to protect people who agree 
to take part in research studies. 
 
If you are concerned about the way this study is being conducted or you wish to make a complaint to 
someone independent from the study, please contact the university using the details outlined 
below. Please quote the study title and protocol number.  
 
The Manager, Ethics Administration, University of Sydney: 
x Telephone: +61 2 8627 8176 
x Email: ro.humanethics@sydney.edu.au 
x Fax: +61 2 8627 8177 (Facsimile) 
x  
        Local contact: Professor Asai Ramish, the chief radiologist Radiology department of National Cancer                            
x Mobile: 99085881 
x Email: asai.ramish@yahoo.com 
 
 
 
This information sheet is for you to keep 
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Discipline of Medical Radiation Science 
Faculty of Health Sciences 
 
 
 
Radiologist performance on ethically different data sets 
 
PARTICIPANT CONSENT FORM 
 
 
I, ................................................................................... [PRINT NAME], agree to take part in this research study. 
 
In giving my consent I state that: 
 
9 I understand the purpose of the study, what I will be asked to do, and any risks/benefits involved.  
 
9 I have read the Participant Information Statement and have been able to discuss my involvement in 
the study with the researchers if I wished to do so.  
 
9 The researchers have answered any questions that I had about the study and I am happy with the 
answers. 
 
9 I understand that being in this study is completely voluntary and I do not have to take part. My 
decision whether to be in the study will not affect my relationship with the researchers or anyone else 
at the University of Sydney and hospitals in Mongolia now or in the future. 
 
9 I understand that I can withdraw from the study at any time. 
 
9 I understand that personal information about me that is collected over the course of this project will 
be stored securely and will only be used for purposes that I have agreed to. I understand that 
information about me will only be told to others with my permission, except as required by law. 
 
9 I understand that the information about me will only be used for this study. 
 
  
 ABN 15 211 513 464 
 
  Professor. Patrick Brennan 
 Professor of Diagnostic Radiography  
 
Room 221 
M Building C42 
Cumberland Campus 
The University of Sydney 
PO box 170 Lidcombe  
NSW 2006 AUSTRALIA 
Telephone:   +61 2 90367402 
Facsimile:  +61 2 90367402 
Email: Patrick.brennan@sydney.edu.au 
Web: http://www.sydney.edu.au/ 
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9 I understand that the results of this study may be published, and that publications will not contain my 
name or any identifiable information about me. 
 
 
I consent to:  
 
 
x Being contacted about future studies  YES  NO  
 
x Receiving feedback about my personal results  YES  NO   
 
 
Would you like to receive feedback about the overall results of this study?  
    YES  NO  
If you answered YES, please indicate your preferred form of feedback and address: 
 
 Postal:  _______________________________________________________ 
 
___________________________________________________ 
 
 Email: ___________________________________________________ 
 
 
 
 
 
 
................................................................... 
Signature  
 
 
 
 ............... .................................................... 
PRINT name 
 
 
.................................................................................. 
Date 
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Safety protocol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Faculty of Health Sciences 
75 East Street 
Lidcombe   NSW  2141   
Australia 
T +61 2 9036 7402 
F  +61 2 9351 9146 
E  patrick.brennan@sydney.edu.au 
sydney.edu.au 
 ABN 15 211 513 464 
CRICOS 00026A 
Professor Brennan’s biography: http://sydney.edu.au/health-sciences/about/people/profiles/patrick.brennan.php 
 
Professor Patrick Brennan  
Professor Diagnostic Imaging, Medical Radiation Sciences 
Associate Dean, International 
 
17 May 2016 
 
 
 
RE: SAFETY PROTOCOL 
 
TO WHOM IT MAY CONCERN 
 
 
The researcher (Delgermaa Demchig) will be conducting the study “Evaluating radiologist 
performance using ethically different data sets”. She will organize a workshop and 
experiment for radiologists in Mongolia. There is no need for a local interpreter as the 
researcher is from Mongolia. No safeguard is required either. 
 
The safety and performance of the experiment will be discussed with the supervisor before 
travelling to Mongolia.  A schedule including date, time and place of experiment will also be 
provided to the supervisor. During the field work, local and supervisor contacts will be made 
via mobile or email at least on a weekly basis. 
 
The researcher will take advice from the following local institutions regarding the safety of 
the planned research process: National Cancer Center in Mongolia.  The researcher’s local 
contact person is: Prof.Asai Ramish. He can be contacted by mobile: 99085881 and email 
asai.ramish@yahoo.com   
  
The researcher has confirmed there is mobile phone coverage in Mongolia that has access 
to global roaming and will have her mobile phone during her field work. There is currently no 
travel warning from the Department of Foreign Affairs and Trade for Mongolia. The 
researcher has subscribed to the travel advice to receive email updates each time the travel 
warning is reissued. No visa is required as the researcher is from Mongolia.  
 
The researcher undertakes to follow the University of Sydney guidelines on Fieldwork Safety 
Standards. 
 
This safety protocol has been agreed and accepted by the researcher and the supervisor.  
 
 
Professor Patrick Brennan (Supervisor)   Delgermaa Demchig (Researcher) 
 
 
 
 
